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INTRODUCTION 
  The prevalence of the disorder varies depending on the definition of dyslipidemia and 
the population studied. In patients with coronary heart disease (CHD), the prevalence of 
dyslipidemia is as high as 80% to 88%, compared to approximately 40% to 48% in age 
matched control without coronary disease. There is a strong correlation between BMI and 
incidence of hypercholestrolemia. The incidence is therefore higher in industrialized countries 
compared to developing countries.(Geneat J J Martin et al,1992) 
A worrisome development is the increase in the rate of risk factors, in developing 
countries, for CHD (including hypercholesterolemia), while the risk factors for CHD decrease 
in prevalence in industrialized countries. However, while there has been a steady decline in 
mortality from heart disease in the US since the early 1960s, it still remains the leading causes 
of death for both men and women of all races and ethnicities.(Pearson T A et al,1999). 
 Lipid and lipoprotein concentrations vary among different populations, with 
countries consuming a western type of diet generally having total cholesterol and LDL-C 
levels than those where regular consumption of saturated fat is low. 
The ideal plasma lipid profile is unknown and varies between different populations, 
even across Europe, and also within a given population. An relationship between total 
cholesterol and the development of coronary heart disease is recognized, as is its contribution 
to the 1 in 4 deaths from coronary heart disease that occurs each year in the U.K.A reduction 
in the mean level of cholesterol in the population will reduce the development of coronary 
atherosclerosis and the prevalence of coronary heart disease. In the individual there is little 
evidence of a level below which a further reduction of total cholesterol od LDL-C is not 
associated with a lower risk of coronary heart disease. 
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   A population approach to screening for raised total cholesterol and LDL-C would be 
expensive to implement and must run in parallel with programmes that identify individuals 
with dyslipidemia and/or other risk factors for coronary heart disease. Some believe only 
individuals under the age of 20 years. (Joseph T Dipro, 
Definition          
 Hypercholesterolemia, an elevation of total cholesterol (TL) and or LDL –cholesterol 
in the blood, is also often referred to as dyslipidemia, to encompass the fact that it might be 
accompanied by a decrease in HDL-cholesterol or an increase in triglycerides. Dyslipidemia is 
classified as serum TL, LDL-cholesterol, triglyceride, Apo lipoprotein B (Apo B) or 
lipoprotein (a) concentrations above 90th percentile, or HDL-cholesterol or Apo lipoprotein 
A-1 concentration below the 10th percentile for the general population. High cholesterol levels 
increase a person’s chance of developing heart disease, particularly, coronary artery disease. 
 
High levels of cholesterol in the blood result in the build up a plaque along the inner 
lining of the arteries. Over time, the build of up plaque leads to a narrowing and hardening of 
the arteries and a reduction in blood flow. This is called atherosclerosis. The presence of 
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atherosclerosis increases a person’s risk of having a heart attack or stroke.(Farmer J A et 
al,1996). 
Lowering cholesterol levels can slow down, reduce, or even stop plaque from 
building up in the arteries. This means, treating high cholesterol levels can reduce a patient,s 
chance of having a heart attack or stroke. 
Treating high cholesterol, levels includes dietary changes, and the use of cholesterol-
lowering medications. High blood cholesterol is also referred to as hypercholesterolemia. It is 
related to hyperlipidemia (elevated levels of lipids in the blood).    
Cholesterol: 
                    Cholesterol was a waxy fat-like substance that was found in all cells of the body 
and in some of the foods. Cholesterol was essential nutrient necessary for many functions 
including: 
¾ Repairing  the cell membranes. 
¾ Manufacturing the vitamin D on  skin’s surface 
¾ Producing hormones such as that estrogen, testosterone 
¾ Possibly helping cell connections in brain that is  an important for learning and 
memory. 
 Regardless these benefits when cholesterol levels rise the blood and that can have 
dangerous consequences depending on that type of the cholestrol and its production stimulated 
by saturated fat. 
Triglycerides: 
                Triglycerides were composed of fatty acid molecules. The the basic chemicals 
contained in that fats in both animals and plants. 
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Characteristics Of The Major Classes Of    Lipoproteins 
Category Composition Origin 
Chylomicrons Exogenous/dietary 
triglycerides 
Gut 
Very-Low-Density-
Lipoproteins(VLDLs) 
Triglycerides Liver 
Intermediate-density 
lipoproteins 
Cholesterol esters and 
Lipoproteins 
VLDL/HDL Catabolism 
Low density lipoproteins Cholesterol VLDL Catabolism 
High-density lipoproteins 
(HDLs) 
Cholesterol Liver and Gut 
 
Lipoproteins: 
                Lipoproteins are spheres that transport cholesterol, triglycerides, or other lipid 
molecules through in the blood stream. Most of that information about that effects of 
cholesterol and triglyceride actually concerns lipoproteins.    
                  Lipoproteins were categorized into 5 types according to size and density and they 
can be further defined and  by that whether they carry cholesterol/triglycerides.   
 Cholesterol-carrying lipoproteins: These were the lipoproteins commonly referred to 
as cholesterol. Low density lipoprotein (LDL): (often called “bad “cholesterol). 
 High Density Lipoprotein (HDL): the smallest and most dense.(often called “good 
“cholesterol. 
9 Triglyceride-carrying lipoproteins. 
 Intermediate density lipoproteins (IDL).They tends to carry triglycerides. 
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 Very low density lipoproteins (VLDL) .These tends to carry triglycerides. 
 Chylomicrons is the largest in size and lowest in density. 
Alternative Names: 
¾ Lipid disorders,  
¾ Hyperlipoproteinemia, 
¾  Hyperlipidemia, 
¾ Dyslipidemia, 
¾ Hypercholesterolemia      
 Effects of lipoproteins and Triglycerides on heart disease. 
Low Density Lipoprotein (LDL), the “Bad” cholesterol .The lowest incidence of  the 
heart disease was usually found in among people who having the  lowest low density 
lipoprotein levels, lowering LDL  is the primary goal of cholesterol drub  of the lifestyle 
therapy. 
LDL transports about 75% of the blood’s cholesterol to the body’s cell’s. It was 
normally harmless. However, if it was exposed to a process called oxidation,  Low Density 
Lipoprotein can penetrate and interact with dangerously with in the walls of the artery that  can 
producing a harmful inflammatory response. Oxidation was a natural process in the body that 
can occurs from chemical combination with unstable molecules. These molecules were 
known as oxygen-free radicals or oxidants. 
High Density Lipoproteins (HDL), the “good” cholesterol: 
High Density lipoprotein (HDL) appears to benefit in the body in two ways: 
¾ Its removes the cholesterol in from the walls of the arteries, returns  to the 
liver for disposal from  body. 
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¾ It helps  to prevent oxidation of Low Density Lipoprotein and High Density 
Lipoprotein actually appears to have its own antioxidants properties. 
¾ It is  might that  fight inflammation. 
HDL (high density lipoprotein) that helps to keep arteries open and reduce the  risk for 
heart attack. High levels of high density lipoprotein (above 60mg/dl) may be nearly as 
protective for heart as  the low levels of LDL.HDL levels below 40mg/dl are associated with 
in increased risk of heart disease. 
Triglycerides: 
Triglycerides interact with HDL (high density lipoprotein) cholesterol in such that 
way that high density lipoprotein levels that falls as triglyceride level rises and  high 
triglycerides may pose other dangers regardless of cholesterol levels. For eg they can may be 
associated with  the blood clot and that form then block the arteries.  
High triglyceride, were  levels  also associated with that inflammatory response- -the 
harmful effect of overactive immune, system that can  be considerable in that  damage to cells, 
tissues and including the arteries. 
Cholesterol, triglycerides goals 
Total cholesterol count includes measurements of LDL (low desity lipoprotein), 
HDL, and triglycerides. The following in that chart summarizes in all lipid goals for all adults. 
Cholesterol Goals For Adults 
Total Cholesterol 
Goals 
LDL Goals HDL Goals Triglyceride Goals 
Less than 200 mg/dl 
is desirable 
70 mg/dl is 
considered an 
Levels above 40 
mg/dl are desirable; 
Below 150 mg/dl is 
normal. 
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important goal in a 
very high-risk 
patients. 
levels above 60 
mg/dl are optimal 
Between 200 and 
239 was a borderline. 
Below 100 mg/dl 
was an optimal for 
everyone. It should 
be the goal for high-
risk people including 
those with existing 
heart disease and 
diabetes and  or two 
or more risk factors 
for heart disease; 70 
mg/dl is an optimal 
goal for these 
individuals.  
 150-199 is borderline 
high  
Over 240 is high   200-499 is high 
   Over 500 is very high 
 130 mg/dl or below 
for people with two 
or more risk factors; 
was 100 mg/dl is an 
optimal goal. 
  
 160 mg/dl ,below for   
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people at less risk 
factors; 130 mg/dl is 
an optimal goal. 
 Anything above 160 
mg/dl is high, with 
levels above,190 
being very high. 
LDL  (loe density 
lipoprotein) levels 
over  
190 require that 
medication even with 
no other cardiac risk 
factors. 
  
 
Risk factors for that  heart disease include in a family history, of early heart problems 
before age 55 for men (before age 65 for women) and smoking, high blood pressure and 
diabetes, being older and were having high density lipoproetein)  levels below 35mg/dl and 
People, with two or more of that  risk factors may have a 10-year risk of  the heart attack that 
can exceeds 20% and may therefore need  that  aim for LDL  (low density lipoprotein) level of 
that 100 mg/dl or below.(Cuche I M et al,2007) 
Classifications of Dyslipidemia 
  Dyslipidemia  that can be the result of genetic predisposition secondary causes, or a 
combination of both. Cholesterol and triglycerides can produce the three forms of 
dyslipidemia: hypercholesterolemia, hypertriglyceridemia,that  and a combination in  both. In 
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each case that dyslipidemia were the result of an that elevation in that either that  number or 
composition of the  specific lipoproteins that which is an important determinant when 
selecting the appropriate drug therapy.    Hypercholesterolemia, was associated with an 
increased concentration of one or more of the cholesterol-carrying lipoproteins (LDL, VLDL, 
HDL) which may can occur because of that  higher concentration of cholesterol in each 
particle an increased number of particles and or a combination of both. Both, very low density 
lipoprotein and LDL  particles that contain one lipoprotein B-100 molecule and therefore  an 
elevation of that Apo lipoprotein B concentration reflects an increased in a number of  that 
cholesterol-containing particles, which was associated with in hypercholesterolemia. 
Conversely the cholesterol content of that chylomicron particles was minimal and  therefore 
an elevation in chylomicron concentrations, rarely causes hypercholesterolemia. Under 
normal situations approximately 70% to 80% of total cholesterol, that  was can be found LDL 
particles. 
  The most of the common cause of hypercholesterolemia, was  an elevation in 
LDL cholesterol. Yet the  total cholesterol was the arithmetic sum of the cholesterol 
found in LDL, HDL, and VLDL particles. Therefore any one or that a combination 
of these particles may be responsible for that  elevation. For example, 
hypercholesterolemia that can  be occur because of that  high HDL cholesterol 
although LDL and VLDL  (very low density lipoprotein) concentrations was within 
acceptable concentrations. 
 One of the most, studied forms of dyslipidemia was familial 
hypercholesterolemia. These patients have to  defective gene from one or both 
parents for the B-E/LDL receptor, significantly reducing their ability to clear LDL 
from the blood. Homozygous familial hypercholesterolemia,  that can be result in 
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four to six times the normal concentration of cholesterol and significant 
atherosclerotic disease and detected during in the teenage years. Heterozygous 
familial hypercholesterolemia, were can cause two to four times  in that  normal 
concentrations of  the cholesterol and with  the premature atherosclerotic disease. 
Polygenic hypercholesterolemia, that  represent the largest group with 
approximately 36%, of the Americans diagnosed with in that  forms of elevated 
cholesterol. These patients tend to have a number of defects the mostly related to 
nutritional and genetic factors resulting were a less active B-E/LDL receptor. 
Cholesterol levels, in  these patients are approximately twice the normal levels. 
  Hypertriglyceridemia that can be  occur  in the patients with high 
concentrations of very low density lipoprotein or chylomicron particles. Most  of the 
cases were mild and that are primarily caused by increased VLDL secretion by  liver 
in patient that who consume an excessive amount of calories  and or alcohol (diet-
induced in hypertriglyceridemia).Very low density lipoprotein secretion  that can 
also increase secondary to diabetes and obesity or other medical problems 
(secondary hypertriglyceridemia). Primary, hypertriglyceridemia were occurs 
because of an over production of triglycerides and very low density lipoprotein 
particles and were often associated with other medical conditions including in 
diabetes and obesity. Hypertriglyceridemia, was not usually an isolated condition. It 
tends to be associated with  that patients who are having low concentrations of HDL 
cholesterol and elevated levels of LDL particles, posing the risk for 
atherogenesis.Mixed hyperlipidemias, are the most common forms of dyslipidemia 
where patients may have elevations in both triglyceride and cholesterol levels. 
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Familial combined hyperlipidemia occurs in approximately 1 in 100 were in 
the population where patients over produce very low density lipoprotein particles 
because of an increased production of Apo lipoprotein B. This increases the 
production of very low density lipoprotein particles  that can result in an elevated 
triglyceride level,an elevated cholesterol level (since VLDL particles may be 
converted to LDL particles that which were  not cleared rapidly and from the system 
and accumulate), or both  in an elevated triglyceride and cholesterol level. The 
features of familial combined hyperlipidemia that  may present differently in 
members of the same family, may even change in a given individual. In general, 
however an elevated Apo lipoprotein B concentrations, the presence of 
hypercholesterolemia or hypertriglyceridemia, that  can be found in family members 
with CAD.       
There  may be a familial basis for the mixed hyperlipidemia, that which may 
result from a deficiency of the lipoprotein lipase enzyme. This deficiency, were 
leads to a reduced ability to delipidize, the triglyceride molecules from that VLDL 
and chylomicron particles. Depending on that situation triglyceride levels can 
increase moderately or severely placing the patient in that at risk for developing the 
Pancreatitis. Therefore the goal of therapy for these patients is to reduce triglyceride 
concentration that can prevent pancreatitis. (Peggy K Han, 2003) 
Etiology 
 The etiology can be classified as, primary and secondary causes. 
  Primary causes are due to single or multiple gene mutations resulting in a disturbance 
of glyceride production or clearance. They vary in location of genetic defect, inheritance 
pattern, prevalence, clinical features, and treatment. All least 18 separate entities have been 
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described. The suspicion for a primary lipid disorder should be especially high in patients with 
premature atherosclerotic disease, a family history of early atherosclerotic disease, a 
significantly elevated serum cholesterol level (>240 mg/dl) and physical signs of 
hyperlipidemia. Most adult cases of dyslipidemia are secondary in nature. In western 
civilizations, sedentary lifestyle and excessive consumption of saturated fats, trans-fatty acids 
and cholesterol are the most important secondary causes. Certain medical conditions are 
commonly associated with dyslipidemia, including chronic renal insufficiency, renal failure, 
diabetes mellitus, hypothyroidism, cholestasis liver disease, and alcohol dependency. Certain 
drugs including high-dose thiazide diuretics, oral estrogens, glucocorticoids, anabolic steroids, 
and atypical antipsychotics, such as olanzapine and clozapine have also been implicated in 
causing mid-to-moderate degrees of dyslipidemia. Several disorders, that are passed down 
through  the families that can led to abnormal cholesterol and triglyceride levels. They include: 
a) Familial Combined Hyperlipidemia 
b) Familial Dysbetalipoproteinemia 
c) Familial Hypercholesterolemia 
a) Familial combined Hyperlipidemia 
Familial combined Hyperlipidemia was a disorder of  an high cholesterol and high blood 
triglycerides that is inherited, which means that it was passed down through families. 
Alternative names: Multiple lipoprotein-type hyperlipidemias 
Causes: Familial combined Hyperlipidemia was the most common genetic disorder, of  that 
increased blood fats that  can causes early heart attacks. However, researchers were not yet 
identified the specific genes responsible. Diabetes, alcoholism and hypothyroidism, that can 
make the condition worse. Risk factors, which include a family history of high cholesterol and 
previous  coronary artery disease. 
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Symptoms: chest pain (angina) may occur. 
b) Familial dysbetalipoproteinemia 
Familial dysbetalipoprotemia was a disorder passed down through  the families in which there 
were in high amounts of cholesterol and triglycerides in the blood. 
Alternative names: Type 3 hyper lipoproteinemia, Deficient or defective Apo lipoprotein 
Causes: A genetic defect, that causes this condition. The disease is linked to defects in the 
gene for Apo lipoprotein E in many cases. Hypothyroidism, Obesity, or diabetes can make the 
condition worse and risk factors for familial dysbetalipoprotenemia, that  include in a family 
history of the disorder or coronary artery disease. 
Symptoms: Symptoms, may not been seen until age 20 or older. Yellow deposits, of fatty 
material in the skin called xanthomas may appear on the eyelids, palms of the hands, soles of 
the fee or in  the tendons of the knees and elbows. Atherosclerosis  is develops at an early age. 
There may be early chest pain (angina) and or  decreased blood flow to specific parts of the 
body and causing transient ischemic attacks of the brain, peripheral artery disease. 
c) Familial hypercholesterolemia: 
Familial hypercholesterolemia is a disorder of high LDL (“bad”) cholesterol that was passed 
down through families, which means that it was inherited. The condition of begins at birth an 
that can cause heart attacks at in an early age. 
Alternative names: Type 2 hyperlipoproteniemia, Hypercholesterolemia xanthomatosis, 
Low density lipoprotein receptor mutation. Causes: familial hypercholesterolemia, was the  
genetic disorder that was can caused by a defect on chromosome 19. 
Symptoms: that may occur include: 
 Fatty skin deposits called xanthomas,that in the of over the elbows, knees and 
buttocks, tendons and around the cornea of the eye. 
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 Cholesterol deposits in that eyelids (xanthelasmas) 
 Chest pain (angina) or  were the other signs of coronary artery disease; may be present 
in an young age.(Pearson T A et al,1999) 
 
 
 
 
Pathophysiology 
Cholesterol Homeostasis   
  Cholesterol was a lipid, that can serves primarily as a precursor to steroid 
hormones, bile acids, as the main component of the cell membranes. Sources of the 
cholesterol needed to carry out  of normal life functions were manufactured by the 
body and ingested from exogenous dietary sources. Cholesterol levels were the 
blood, reflect approximately 40% to 60% endogenous cholesterol and with the 
balance coming, from dietary sources. Triglycerides which are composed of fatty 
acids esterified to glycerol and used as energy substrates, were supplied by fats in 
that diet, through the conversion of carbohydrates by the liver. 
 Cholesterol and triglycerides were other lipids in that body were transported 
through that bloodstream in a spherical particles, called lipoproteins. Lipoproteins 
can be divided, into five major categories depending on that composition. 
  The classes from largest and least dense to smallest and most dense are 
chylomicrons and (VLDL), (IDL),(LDL), and (HDL). The larger more particles 
primarily were have a triglyceride-rich core, while the smaller, more dense particles 
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have a cholesterol ester core. LDL,that can accounts for approximately 60% to 70% 
of total serum cholesterol and was the primary atherogenic class of lipoproteins. 
High density lipoprotein constitutes approximately 20% to 30% of total serum 
cholesterol with vey low densiy lipoprotein comprising about 10% to 
15%.Cholesterol was derived from two sources: exogenously from the systemic 
circulation and endogenously via intracellular synthesis (Figure 1).  
 
 
The exogenous lipoprotein system was responsible for the synthesis and 
transportation  and catabolism of chylomicron particles remnants. Saturated 
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monounsaturated, polyunsaturated fats, cholesterol esters digested,absorbed in the 
proximal small bowel were reformulated and packaged into chylomicrons by cells in 
the intestinal endothelium. Thus chylomicrons were primarily composed of fatty 
acids and cholesterol, apolipoproteins that were obtained from the diet. These 
chylomicrons then that  enter the lymphatic system, travel through the body until 
they were broken down by the enzyme lipoprotein lipase in that capillary beds to 
chylomicron remnants, which were smaller and contain less fatty acids and but have 
retained apolipoproteins B-48 and E. These remnants were then cleared from the 
circulation by the LDL-related receptor protein found in that liver. In addition to 
replenishing their cholesterol, pools by taking up circulating lipoproteins from 
exogenous sources and cells that can also synthesize their own cholesterol through 
the endogenous pathway. The intracellular synthesis of cholesterol involves a series 
of biochemical reactions starting with acetyl-CoA Figure 
2.
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The rate-limiting enzymes involved in that  process were HMG-CoA 
syntheses and which can catalyzes the conversion of acetyl- CoA to HMG-CoA, and 
HMG-CoA reductase, in which can catalyzes the conversion of hepatic  in HMG-
CoA to mevalonic acid, used in a later step in the biosynthesis of cholesterol. The 
statins, HMG-CoA reductase inhibitors and competitively inhibit this enzyme and 
reduce the capacity of the cell to synthesize cholesterol. 
Fatty acids , cholesterol produced by the body were then transported through 
the endogenous pathway (Figure 1).Three major lipoproteins,was  involved in this 
pathway. Triglycerides, that  can be synthesized by the liver, especially in the 
presence of excess carbohydrates, later secreted into the bloodstream as VLDL. 
These very low density lipoprotein particles contain approximately five times more 
triglycerides than cholesterol and also contain apolipoproteins B-100, E, and C-II. 
The B,E proteins link with B-E or LDL cell surface receptors while apolipoprotein 
C-II functions as a cofactor for the enzyme lipoprotein lipase. Once secreted, into 
the bloodstream and triglyceride molecules were hydrolyzed from the very low 
density lipoprotein particles by lipoprotein lipase and  located in that capillary beds. 
On release these free fatty acids were used for the energy production primarily by 
heart and skeletal muscle, or stored in fat cells. Nonetheless, this process of lipolysis 
decreases the triglyceride content, size of the very low density lipoprotein particles 
and preparing them for either of their two known metabolic fates.Clearance, via the 
hepatic remnant receptor and further release of triglyceride resulting in that 
formation of IDL particles.  
 IDL particles were high in triglyceride content and contain almost all of the 
cholesterol initially contained in the VLDL particles. Lipolysis, continues through 
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the actions of lipoprotein lipase, hepatic lipase and leading to much and smaller 
cholesterol-rich LDL particles. By this time apolipoproteins, E and C have been 
removed and leaving only apolipoprotein B-100 on the LDL particles. IDL particles 
were intermediate products between VLDL and LDL particles ,therefore have a 
short life span. Their cholesterol, triglyceride contents do not significantly impact 
cholesterol measurements. Except for rare dyslipidemias, less than 5% of cholesterol 
circulates in  that IDL particles. Half of these IDL particles was to cleared from the 
circulation by the LDL receptor while the other half was converted to LDL particles. 
 LDL was the primary atherogenic lipoprotein and the smaller the size of the 
LDL particle the more it was able to penetrate into sub endothelial tissue, where it 
contributes to the development of atherosclerosis. Excessive circulating, low density 
lipoprotein cholesterol will cause cholesterol deposition outside of the cell that 
causing atherogenic plaque in the formation of the vascular endothelium potentially 
leading to that coronary artery disease.Two specific types of low density lipoprotein 
particles have recently been identified to be highly associated with coronary heart 
disease risk. The first, a lipoprotein particle was a very small LDL particle 
surrounded by a plasminogen-like protein. The other subclass of small  dense LDL 
particles was referred to as atherogenic lipoprotein phenotype B. This subclass was 
found in an approximately 30% of the population and was associated with a high 
risk of CHD. 
 The third major lipoprotein that involved in the endogenous pathway was 
high density lipoprotein. Similar to low density lipoprotein particles and HDL 
particles were rich in cholesterol and very small. However high density lipoprotein 
particles appear to be involved the ireverse cholesterol transport resulting in an anti 
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atherogenic effect. Specifically high density lipoprotein may prevent or remove 
cholesterol deposits within the arterial wall. Other possible explanations, for the 
beneficial role of high density lipoprotein cholesterol include the following:  
Prevents low density lipoprotien oxidation by working as an antioxidant;  Reduces 
platelet agreeability by increasing prostacyclin production, Stabilizes serum 
prostacyclin and promotes fibrinolysis, Competitively inhibits the uptake of low 
density lipo protein by endothelial cells; Prevents LDL aggregation and uptake by 
macrophages;  Decreases cholesterol and foam cell formation; and  Inhibits platelet 
activation by LDL through the phosphatidylinositol cycle.  
   An important function of high density lipoprotein was that it can serve as a 
marker for abnormal metabolism of chylomicrons and very low density 
lipoproteinparticles and  because as triglycerides increase and  high desnity 
lipoproteindecreases. Two key enzymes were  involved in the transport of 
cholesterol from the periphery to the liver, where that  can be eliminated by 
particles. Lecithi lipoprotein-cholesterol acyltransferase was responsible for 
converting the cholesterol in high density lipoprotein particles into insoluble 
cholesterol esters causing them to partition core of these lipoproteins. The other 
enzyme and cholesterol ester transfer protein were  involved in the transfer of 
cholesterol esters from HDL particles to triglyceride-rich particles in exchange for 
triglyceride molecules. Once invery density lipoprotein and intermideate density 
lipoprotein  particles cholesterol was transported to the liver for elimination (Figure 
1). 
All three lipoproteins were highly involved in that transport of triglycerides 
and cholesterol from the liver to the body where they may be used by cells and from 
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the body, to the liver where they may be eliminated. If the amount of cholesterol was 
insufficient to meet the requirements of any cell, the cell will up-regulate its 
synthesis of the LDL receptor. The newly formed, LDL receptor will migrate to an 
area on the surface of the cell called the coated pits. Once in the coated pits the cell 
was capable of recognizing circulating lipoproteins that contain either apolipoprotein 
E or B.Both the very low density lipoprotein and IDL particles contain both B and E 
proteins  therefore may have a higher binding affinity for the LDL receptor than the 
LDL particles. Once binding occurs the lipoproteins are internalized by the cell 
taken up by liposomes  broken down into elemental substances to be used by the 
cell. The LDL receptor protein returns to the cell surface where it can be bind with 
another circulating lipoprotein and repeating the process again. 
Link Between Cholesterol and CHD 
 The processes by which lipids and lipoproteins participate in the 
atherosclerotic plaque formation and CHD events continue to be an area of 
controversy and research. One of the initiating events of atherosclerotic plaque 
formation appears, to be the entrance of lipoproteins low density lipoprotein and Lp 
(a) into the sub endothelial space, with their oxdatively modified free radicals 
produced by smooth muscle cells and activated macrophage endothelial cells. These 
oxidatively modified lipoproteins enter macrophages through a scavenger receptor 
pathway ultimately yielding lipid-rich foam cells. Circulating monocytes were also 
attracted to smooth muscle, endothelial cells by chemo attractant that was 
augmented by the oxidatively, modified lipoproteins. 
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As the macrophage scavenger receptor continues to uptake oxidatively 
modified lipoproteins foam cells continue to form and progress to the next level of 
atherogenesis which was in  the formation of the fatty streak. At the same time the 
smooth muscle cells migrate into the sub endothelial space ,begin proliferating  
contributing to the overall atherogenic process. As the process continue lesions 
continue to grow by increased smooth muscle cell proliferation was collagen 
synthesis. At this point and necrosis of the foam cell  formation of an extracellular 
lipid core occurs as long as plasma LDL levels are elevated. The final phase appears 
to involve  in an autoimmune inflammatory response that can causes T lymphocyte 
infiltration of the adventitia. This inflammatory response that appears to complete 
the process of plaque formation that wasthe underlying culprit in CHD. 
 Symptoms 
  There was no warning signs for high low density lipoprotein and other unhealthy 
cholesterol levels. When symptoms finally occur they usually take the form of angina (chest 
pain), heart attack in response to the buildup of atherosclerotic plaque in the heart disease.( 
Pegg.. k .Han et.al. 
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2000),
 
 
 
 
Risk Factors 
   Unhealthy cholesterol levels increase the risk for heart disease and heart 
attack. Some risk factors, for cholesterol can be controlled (diet, exercise, weight) 
while others cannot (age, gender, and family history). 
Age and gender: 
From puberty on men tend to have lower HDL (“good” cholesterol) levels 
than women. One reason were that the female sex hormone estrogen was associated 
with higher HDL levels. Because of this, pre menopause and as estrogen levels and 
decline women, catch up in their rates of heart disease. Throughout the menopausal 
years and high density lipoprotein levels decrease and bad  cholesterol and 
triglyceride levels increase. For men, low density lipoprotein and triglyceride levels 
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also rise as the age and the risks for heart disease increase as well.There was some 
evidence that high triglyceride levels carry more risks for women than men.Heart 
disease, was the main cause of death for both men and women. 
Children and adolescents: 
Children, who have abnormal cholesterol levels were at increased risk of 
developing that  heart disease later in the life. However, it was difficult to 
distinguish “normal” cholesterol levels occur between genders and population 
groups. Cholesterol levels tend to naturally rise sharply until puberty and decrease 
sharply, then  that rise again. 
Genetic factors and family history: 
Genetics play an major role in determining a person blood cholesterol 
levels.children from families with a history of premature heart disease should be 
treated for cholesterol levels after they are 2 years old. Genes may influence whether 
a person have low high density lipoprotein levels, high low density levels, high 
triglycerides  and  high levels of other lipoproteins such as lipoprotein(a). 
Inherited cholesterol disorders include: 
9 Familial hypercholesterolemia was a genetic disorder that causes high 
cholesterol levels and particularly LDL, premature heart disease. It 
occurs in an mainly as 1 in 500 people. 
9 Familial lipoprotein lipase deficiency was a very rare disorder that 
causes depletion of lipoprotein lipase. This was an enzyme that appears 
to be important in the removal of lipoproteins that were rich in 
triglycerides. People who were deficient in it have high levels of 
cholesterol , fat in their blood. 
Chapter 1                                                                                     Introduction 
 
Department of Pharmacy Practice J.K.K.M.M.R.F College of Pharmacy 
 
24
Life style factors: 
Diet: The primary dietary elements that  can lead to unhealthy cholesterol include 
saturated fats (found mainly in red meat, egg yolks, and high-fat dairy products) and 
transfatty acids (found in fried foods and some commercial baked food 
products).shellfish  was also high in dietary cholesterol. 
Weight: Being overweight, obese increases the risk for unhealthy cholesterol levels. 
Exercise: Lack of exercise can contribute to weight gain, decrease lipoprotein in that 
high density lipoprotein in HDL levels and increase in LDL and total cholesterol 
levels. 
Smoking: Smoking reduces that HDL cholesterol and promotes build-up of fatty 
deposits in the coronary arteries. 
 
 
Obesity, Metabolic syndrome, and type 2 diabetes: 
The effect of obesity on cholesterol levels is complex. Overweight 
individuals tend to have high triglycerides ,LDL levels ,low HDL levels. This 
combination was a risk factor for heart disease. Obesity also causes other effects 
(high blood pressure, increase in inflammation) that pose major risks to the heart. 
Obesity was particularly dangerous when it is one of the components of the 
metabolic syndrome  formerly known as syndrome x. This syndrome consists of 
obesity marked by abdominal fat and unhealthy cholesterol levels and high blood 
pressure,insulin resistance. Metabolic syndrome wasa pre-diabetic condition that is 
significantly associated with heart disease and higher mortality rates from all causes. 
Many doctors recommend that patients with metabolic syndrome should be 
aggressively treated with high-dose statin therapy to lower LDL levels. 
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Obesity was also strongly associated with type 2 diabetes, which itself poses 
a significant risk for high cholesterol levels and heart disease. 
Children who are overweight was at higher risk for high-triglycerides and 
low HDL, which may be directly related to later unhealthy cholesterol levels. 
Childhood LDL levels and body-mass index (BMI) were strongly associated with 
cardiovascular risk during adulthood. Overweight and obese children who have high 
cholesterol should also get tested for high blood pressure and diabetes other 
conditions associated with metabolic syndrome.( Fredrickson D S et al,1967) 
 
 
 
 
 
Other Medical Conditions: 
 High blood pressure: 
High blood pressure (hypertension) contributes to the thickening of heart’s blood 
vessel wall which can worsen atherosclerosis (accumulated deposits of cholesterol in 
the blood vessels).High blood pressure high cholesterol, diabetes all work together 
to increase the risk for developing heart disease. 
 
 Hypothyroidism: 
Low thyroid levels (hypothyroidism) were associated with higher risk for high 
total and low density lipoprotein cholesterol, and triglycerides. Treating the thyroid 
condition  that can significantly reduce cholesterol levels. Research was mixed on 
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whether mild hypothyroidism (subclinical hypothyroidism) was associated with 
unhealthy cholesterol levels. 
 
 Polycystic ovarian syndrome: 
Women with this endocrine disorder may have increased risk for high 
triglyceride and low HDL levels. This risk, may be due to the higher levels of the 
male hormones testosterone associated with this disease. 
 Kidney Disease: 
Kidney disease, increases the risk of heart disease. 
 Other risk factors: 
Medications. Certain medications, such as specific antiseizure drugs, 
corticosteroids,isotretinoin (Accutane) may increase lipid levels. 
Diagnosis 
Blood tests can easily measure cholesterol levels. A blood test for cholesterol,that  
should include the entire lipoprotein profile low density lipoprotein, total cholesterol,high 
density lipoprotein and triglycerides. It is very difficult to measure low density lipoprotein 
levels by themselves and but low density lipoprotein levels can reliably calculated using total 
cholesterol and high density lipoprotein levels. 
To obtain a reliable cholesterol reading, doctors advise: 
¾ Avoid strenuous exercise for 24 hours before the test. 
¾ Do not eat and drink anything but water for 12 hours forehand. 
Chapter 1                                                                                     Introduction 
 
Department of Pharmacy Practice J.K.K.M.M.R.F College of Pharmacy 
 
27
¾ If the test results were abnormal in second test should be performed between 1 week 
and 2 months after the first test.(Lichtenstein A H et al, 2006) 
Screening Guideline: 
Periodic cholesterol testing was recommended in all adults and  but the major national 
guidelines differ on the age to star testing. 
¾ Recommended starting ages, were between 20-35 for men and 20-45. 
¾ Adults with normal cholesterol, diabetes, kidney problems, heart disease, and other 
conditions require more frequent testing. 
Screening with a fasting lipid profile recommended for children WHO: 
¾ Have risk factors such as family history of high cholesterol and history of heart attacks 
before age 55 for men and before age 65 for women. Screening should begin as early 
as age 2 and no later than age 10. 
¾ Are Obes or who have diabetes. If the child’s cholesterol level tests normal and 
retesting was recommended in 3-5 years. Patients already being treated for high 
cholesterol should every 2-6 months. (Stefanick M L et al, 1998) 
Treatment Approach 
   Lowering cholesterol level reduces risk of heart disease and stroke. Studies 
that  have shown that for every 1% reduction in cholesterol levels there was a 25% 
reduction in the rate of heart disease. People who already have heart disease or are at 
higher risk, benefit most from lowering their cholesterol. 
Life style: 
A number of lifestyle changes were recommended in those with high 
cholesterol including: smoking cessation and  limiting alcohol consumption, 
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physical activity and maintaining a healthy weight and a diet low in saturated fats. In 
strictly controlled surroundings, a diet that  can reduce cholesterol levels by 15%.In 
practice dietary advice can provide a modest decrease in cholesterol levels and may 
be sufficient, in the treatment of mildly elevated cholesterol.(Tosi I et al, 2007) 
Medications: 
 
If low density lipoprotein cholesterol remains high after changing diet and 
exercise habits doctor may prescribe medications to lower it. If cholesterol,was very 
high (more than 200mg/dl) may start drug therapy, at the same time improve our diet 
and exercise habits. Drugs commonly used to treat high cholesterol include. (Jones P 
H,et al,2003) 
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a. Statins 
Statins were the most effective drugs for the treatment of high cholesterol, 
particularly for lowering LDL levels. They also have modest effects in lowering 
triglycerides, increasing HDL levels. Statins inhibit the liver enzyme HMG-COA 
reductase, which the body uses to manufacture of cholesterol. These drugs 
effectively, reduce the risk of major coronary events including first and second heart 
attacks and stroke in adults with unhealthy cholesterol levels. 
 
Brands: statins, approved in the U.S include: 
• Lovastatin,Pravastatin,Simvastatin, Fluvastatin,Atorvastatin,Rosuvastatin 
Statins, may also be prescribed fixed dose combination drugs which combined 
two drugs in one pill: Statins that  may be prescribed along with other cholesterol-
lowering drugs such as bile acid binding resins and nicotinic acid and fibrates. 
b) Niacin (Nicotinic acid): 
Brands: Nicotinic acid was the active compound found in niacin, or vitamin B3.It 
was a particularly helpful choice for patients with low high density lipoprotein 
levels. Brands include Niacor, Nicolar and slo-Niacin. An extended release forms 
(Niaspan), administered at bedtime, may have fewer side effects, including 
headaches and flushing, than rapidly-acting Niacin drugs. Although niacin was 
available over the counter and the active form used for cholesterol treatment was 
given in  much higher doses. It was an important to take this medication under a 
doctor’s direction in order to ensure its safety and effectiveness. (Weis M R et al, 
2000) 
Benefits: When used in high doses  niacin has the following benefits: 
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¾ Rasies HDL levels higher than other anti-cholesterol drugs. 
¾ Reduces, triglyceride levels are very effectively. 
¾ Lowers low density lipoprotein-cholesterol and lipoprotein (a) 
¾ Costs, less than other anti-cholesterol drugs. 
C) Fibrates: 
Brands: Fibrates that,break down the particles that make triglycerides. Gemfibrozil 
was standard fibrate. It was usually taken twice a day and 30 minutes before 
breakfast, before the evening meal. Other fibrates includes fenofibrate and 
benzafibrate .This may be in more effective lowering cholesterol than gemfibrozil. 
(Baigent C et al, 2007) 
Benefits: Fibrates were having the following effects on cholesterol and lipids other 
factors: 
¾ They were good choices for many patients who need to lower triglyceride 
levels, increase HDL but who cannot take other drugs used for these purpose, 
such as nicotinic acid. 
¾ Fibrates that can produce modest reductions in LDL levels, although not as 
effectively as statin or other drugs. LDL may actually increase in patients 
with very high triglycerides who take these drugs. (The newer fibrates are 
much more effective in lowering LDL than gemfibrozil). 
¾ Fibrates, that may lower the risk of heart attack. 
 
D) Bile-Acid Binding Resins 
       Bile-acid binding resins work and  as their name suggests by binding to bile in 
the digestive tract. This reduces cholesterol in that  following way, 
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• Bile was made in the liver and was used as one of the body’s primary 
manufacturing components. 
• Once the resins bind to bile in the digestive tract  the bile in the digestive 
tract andthe bile is excreted in feces. 
• As the resins eliminate bile from the body and the liver takes more 
cholesterol from the blood stream in order to produce more bile. 
• As cholesterol was taken out of the blood stream LDL levels drop. 
E) Ezetimibe: 
              Ezetimibe blocks absorption of cholesterol that comes from food.Ezetimibe 
was usually prescribed alone as in combination with fenofibrate  for reduction of 
total cholesterol and low density lipoprotein in patients with mixed hyperglycemia 
(high LDL levels, high triglycerides, Low HDL levels) whose cholesterol has not 
been adequatly, controlled through diet alone.(Byington R P et al,1995) 
Guidelines: 
Various clinical practice guidelines have to addressed the treatment of 
hypercholestrolemia.The American College Of Physicans, have be addressed that 
the treatment of hypercholesterolemia in patients with diabetes. Their four 
recommendations are: 
1. Lipid-lowering therapy should be used for secodary prevention of cardiovascular 
mortality, morbidity for all patients “(both men and women) with known coronary 
artery disease ,type 2 diabetes. 
2. Statins should be used for primary prevention against macrovascular 
complications in patients (both men and women) with type 2 diabetes and other 
cardiovascular risk factors. 
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3.Once lipid-lowering therapy is initiated, patients with type 2 diabetes mellitus 
should be taking at least moderate doses of statin (the accompanying evidence report 
states “simvastatin,40 mg/dl;pravastatin,40 mg/dl;atorvastatin,20 mg/d; or an 
equivalent dose of another statin”). 
4. For those patients with type 2 diabetes who are taking statins,routine monitoring 
of liver function tests or muscle enzymes is not reccommended except in specific 
cirumstances.( Kawada T et al, 2002) 
Alternative Medicine 
 According to survey in 2002,alternative  medicine was used in an attempt to 
treat cholesterol by 1.1% of U.S adults.Consistent with previous surveys,this one 
found that the majority of individvals (i.e.,55%) used it in conjuction with 
conventional medicine.A review trials of phytosterols and/or phytostanols reported 
an average of 9% lowering of LDL –Cholesterol.In 2000 the food and Drug 
Administration approved the labelling of foods containing specified amounts of 
phytosterol esters or phytostanols esters as cholesterol lowering;in 2003 an FDA 
Interim Health Claim Rule extended that label claim to foods or dietary supplements 
delivering more than 0.8 grams/day of phytosterols or phytostanols.Some 
researchers,however,are concerned about diet supplementation with plant 
sterolesters and drawn attention to significant safety issues.(Brugts J J et al,2009) 
                  
                       Health Related Quality Of Life  
Definition: 
 Health related quality of life is a multi-dimensional concept that can 
encompasses the physical and  emotional andsocial components  that associated with 
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an illness or its treatment. There are five main dimensions of HRQoL: (1) physical 
functioning, (2) psychological functioning, (3) social functioning, (4) cognitive 
functioning, and (5) general well-being (John E. Warw, Jr., PhD et.al., 2008). 
Sf-36v2 Health Survey 
 The sf-36v2 Health survey (SF-36V2; ware et al;2007) is developed to be a 
brief, board, generic measure of eight domains, or aspects of health status that are 
considered important in describing and monitoring individuals suffering from a 
disease/illness. Although it measures these domains in the terms of functioning, 
behaviorally more subjective states and or personal evaluations, it is not intended to 
be a comprehensive survey of health. The SF-36V2 maintains comparability with its 
predecessor, the SF-36 Health Survey (SF-36) by retaining and improving on the 
same domains, component summary measures, and items the original version of the 
instrument. 
 This SF-36V2 administration guide was developed to meet the needs of 
clinical trial investigator using electronic SF-36V2 scoring and reporting services 
from quality metric incorporated. The focus of this guide is to provide investigators 
administering the SF-36V2 as part of a clinical trial with the information required to 
administer the instrument and to then correctly enter valid data obtained from the 
administration. To assist in this task, a description of SF-36V2 concepts, measures 
and forms is first provided as an introduction to administration, data entry, and data 
quality guidelines. (Ware et al.,2007) 
Health Domain Scales. 
 The SF-36V2 includes one favorably scored scale measuring each of eight 
health domains: Physical health problems (role-physical), bodily pain, General 
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health, Vitality, Social Functioning, Role participation with emotional health (role-
emotional) and mental health. (Kosinski, Ware,Bayliss et.al.,1995) 
Physical Functioning (PF) 
  The content of the 10 item PF scale reflects the importance of distinct aspects 
of physical functioning and necessity of sampling a range of severe and minor 
physical limitations. Items represent levels and kinds of limitations between the 
extremes of physical activities, including lifting and carrying groceries; climbing 
stairs; bending, kneeling, or stopping; and walking moderate distance. One self-care 
item is included to represent limitations in self-care activities. The Physical 
functioning items capture both the presence and extent of physical limitations in 
self-care item is included to represent limitations in self-care 
activities.(Garratt,A,N.,Schmidit,L.,Mackintosh et.al.,(2002) 
Role-Physical (R.P) 
The four-item role-physical scale covers an array of physical health-related 
role limitations, including (a) Limitations in the kind of work or other work or other 
usual activities, (b) reductions in the amount of time spent on work or other usual 
activities, (c) difficulty performing work or other usual activities, (d) accomplishing 
less. 
 
Bodily Pain (BP) 
The BP scale comprises two items: one pertaining to the intensity of bodily 
pain and one measuring the extent of interference with normal work activities due to 
pain. Low scores indicate high levels of pain that impact normal activities, whereas 
high scores indicate no pain and no related impact on normal activities. 
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General Health (GH) 
The GH scale consists of five items, including a rating of health (excellent to 
poor) and four items addressing the respondent’s views and expectations of his or 
her health. Low scores indicate evaluation of general health as poor and likely to get 
worse. High scores indicate that the respondent evaluates his or her health most 
favorably. 
Vitality (VT) 
This four-item measure of vitality (i.e., energy level and fatigue) was 
developed to capture differences in subjective well-being. Low sores indicate 
feelings of tiredness and being worn out. High scores indicate feeling full of energy 
all or most of the time. 
Social Functioning (SF) 
This two-item scale assesses health-related effects on quantity and quality of 
social activities, asking specifically about the impact of either physical or emotional 
problems on social activities. 
Role-Emotional (RE) 
The three-item RE scale assesses mental health-related role limitations in 
terms of (a) time spent doing work or other usual activities, (b) amount of work or 
activities accomplished, and (c) the care with which work or other activities were 
performed. 
Mental Health (MH)  
The five-item MH scale includes one or more items from each of four major 
mental health dimensions (anxiety, depression, loss of behavioral/emotional control, 
and psychological well-being).Low scores on MH are indicative of frequent feelings 
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of nervousness and depression, whereas high scores indicate feelings of peace, 
happiness, and calm all or most of the time. 
Reported Health Transition (HT) 
A general health item asks respondents to rate the amount of change they 
experienced in their health in general over a 1-year period on the standard (4-week) 
form or over a 1-week period on the acute (1- week) form. 
Physical And Mental Component Summery (Pcs And Mcs Measures) 
  The measurement model, or conceptual framework, underlying the 
construction of the SF-36V2 multi-item health domain scales and component 
summery measures. This model has three levels: 
(a) Items, (b) health domain scales that aggregate items, (c) component 
summary measures that aggregate the health domain scales. 
  The aggregates of the health domain scales are referred to as component 
summary measures because they were derived and scored using a factor analytic 
method called principal components analysis (Harman, 1976).Although they reflect 
the two broad components or aspects of health-physical and mental-all of the eight 
health domain scales are used to scores both component summary measures. All but 
one of the 36 items (item2, self-reported health transition). 
(Ware,J.E.,Jr.,Snow,K,K.,(1993). 
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      Table 1: Abbreviated Item Content For Health Domain Scales 
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LITERATURE  REVIEW 
1.J.Muller-Nordhorn,et.al.,(2011),was conducted a study of effect of an 
adherence-enhancing program on HRQoL of life in patients with 
hypercholestrolemia.In study  Health-related quality of life (HRQOL) is an 
important outcome.HRQOL has been shown to be associated with adherence to 
medication and lifestyle recommendations.Result of this study is a total of 7640 
patients are included.HRQOL was inversely related to disease severity in all scales 
but the mental SF-12 summary scale.Patients in the adherence program had 
significantly higher physical SF-12 scores during follow-up compared to 
controls,independent from any lipid-lowering effect.The conclusion of this study is 
the adherence-enhancing program had a significant benefit on physical HRQOL in 
patients with statin therapy.However,the benefit was not associated with improved 
adherence to lipid-lowering therapy on the individual level and thus should rather be 
understood a unspecific program effect.Also, the obsereved effect does not appear to 
be clinically relevant 
2.Nelva Mata,Rodrigo Alonso et.al.,(2011),reported a cross-sectional study of 
clinical characteristics and evaluation of LDL-Cholesterol treatment of Spanish 
Familial Hypercholestrolemia Longitudinal Cohort study.Method and Result of this 
study is demographic,lifestyle,medical and therapeutic data were collected by 
specific surveys.Data from 1852 subjects (47.5% males) over 19 years old were 
analyzed: 1262 (68.1%,mean age 45.6 years) had genetic diagnosis of FH and 590 
(31.9%.mean age 41.3 year were non-FH.Conclusion of the study is most of this 
high risk population is receiving LLT,prevalence of cardiovascular disease and 
LDL-c levels are still high and far from the optimum LDL-c therapeutic 
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goal.However,LDL-c levels could be reduced by using  more intensive LLT  such as 
combined therapy with maximum statin dose and ezetimibe. 
3.Vilma Raskeliene,Marijia Ruta Babarskine,et.al.,(2009),conducted a study of 
Impact of duration and treatment of arterial hypertension on health-related quality of 
life.The method  a total of 101 patients (19 males and 82 females) met the inclusion 
criteria and consented to participate in the study,Their  mean age was 58.03+_5.63 
years.The patients quality of life was evaluated using the medical outcomes study 
short form 36- item questionnare (SF-36 questionnare),which comprises 36 
questions grouped into eight domains.The result of the study is subjects with AH 
showed lower  values compared to normotensive patients in the following 
domains:Physical functioning (p=0.014),role limitations due to physical health 
(p=0.012),energy/vitality (p=0.016),and general health evaluation (p=0.023).This 
study concluded that the patients with AH reported lower quality of life in the 
following domains:physical functioning,role limitations due to physical 
health,energy/vitality,and general evaluation of health.Compared to patients without 
AH,the quality of life of the patients who had the effective treatment did not 
differ,whereas patinets with  ineffective treatment had the lower quality of 
life.Functioning is more statistically significantly limited due to physical health in 
patients with AH. 
4.Ford ET .AL., (2008) conducted a cross-sectional study of gender difference in 
coronary heart disease and health related quality of life:finding from 10 states from 
the 2004 behavioral risk factor surveillance system.The main objective of this study 
was to examine differences in health-related quality of life (HRQoL) between 
people with coronary heart disease (CHD) and those without this condition in 
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population based sample of U.S. adults and toexamine the interaction between CHD 
and diabetes on HRQoL.The result of study was performed a cross sectional analysis 
of data from 50,573 participants aged >_ 18 years from 10 states of the 2004 
Behavioral Risk Factor Surveillance system(BRFSS).Data were self-reported.They 
concluded that the people with CHD have significantly improved HRQoL Compared 
with those without CHD.HRQoL among women with CHD is worse than that 
among men with CHD. 
5. Didem Arslantas,Unal Ayranci,et.al.,(2008)was conducted a population based 
cross-sectional study of prevalence of hypertension among individuals aged 50 years 
and over and its impact on health related quality of life in a semi-rural area of 
western Turkey.The method of this study is population based cross-sectional study 
was conducted in two settlements ina region of western Turkey between March 1 
and April 30.2007. A questionnaire concerning life habits associated with 
hypertension,medical histories,and demographic characteristics is filled in by a face 
to face interview.The SF-36 scale is used to assess HRQoL.Body mass index (BMI) 
is calculated by measuring the weight and length of the body.The result of this study 
is HRQoL is better in hypertensive patients whose blood pressure is under control, 
whereas it isworse in those with at least one chronic disorder accompanying 
hypertension (p<_0.05,for each one).This study concluded that great emphasis 
should be placed on the need for a public health program for the detectio,prevension, 
and control of hypertension, including other risk factors,as well as for the 
modification of foods and life habits,specifically in individuals who are most likely 
to be at risk of hypertension. 
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6.Ashraf Eljedi,et.al.,(2006) was conducted a Health related quality of life in 
diabetic patients and controls without diabetes in refugee camps inGaza strip:a 
cross-sectional study.In this study the prevalence of diabetes mellitus is increasing in 
developed and developing countriesDiabetes is known to strongly affect the health-
related quality of life (HRQoL).HRQoL is also influenced by living conditions.The 
result of the study that all domains were strongly reduced in diabetic patients as 
compared to controls,with stronger effects in physical health (36.7 vs 75.9 points of 
the 0-100 scores) and psychological domains (34.8 vs 70.00 and weaker effectsin 
social relationships (52.4 vs 71.4) and environment domains (23.4 vs 36.2).The 
impact of diabetes on HRQoL was especially severe among females and older 
subjects (above 50 years).Low scioecnomic status had strong negative impact on 
HRQOL in the younger age group (<50 years).The conclusion of the HRQoL is 
strongly reduced in diabetetic patients living in refugee camps in the Gaza 
strip.Women and older patients are especially affected. 
7.I-C Huang,et.al.,(2006) reported a study based on the relationship of excess body 
weight and health-related quality of life:evidence from a population study in 
Taiwan.The method of the cross-sectional study used a national representive sample 
(n= 14221) from the 2001 Taiwan National Health Interview survey.Body weight 
was categorized using body mass index (BMI in kg/m2) as normal (18.5-24.9), 
overweight (25-29.9), and obese (>- 30).HRQoL was measured using the Taiwan 
version of the SF-36.  The result of the study is unadjusted physical HRQoL was 
best for normal weight,worse for overweight, and worst for obese individuals.For 
unadjusted mental HRQoL, overweight subjects had at least as good mental domain 
scores of HRQoL as those with normal weight or obesity,depending on the 
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subscales.This study is concluded that in Taiwan,excess weight was related to worse 
physical,but not mental HRQoL.The  lack of impact of increased body weight on 
mental health status presents a potential challenge to preventing the increases in 
obesity.More Research is needed to elucidate the mechanisms by which excess 
weight affects specific domains of HRQoL, and to develop effective prevention 
strategies. 
8.Hwee-Lin Wee,Yin-Bun Cheung,et.al.,(2005) reported a cross-sectional study in 
the impact of diabetes mellitus and other chronic medical conditions on health-
related quality of life.The main background of  diabetes mellitus is an important 
public health concern,the impact of which is increased by the high prevalence of co-
exesting chronic medical conditions among subjects with DM.The results of this 
study  is among 5,224 subjects, the prevalence of DM,HTN,HD and MS were 
5.9%,10.7%,2.4% and 26.6% respectively.DM lowered SF-36 scores by more than 2 
points on 3 SF-36 scales and lowered SF-6D scoresnby 0.03 points.Subjects with 
DM and HTN,DM and HD or DM and MS experienced further lowering SF-36 
scores exceeding 2 points on atleast 6 scales and fruther lowering of SF-6D scores 
by 0.05,0,08 and 0.10 points  respectively.Generally,DM and co-existing medical 
conditions exerted additive effects on HRQoL,with the exception of DM and heart 
disease,where a subtractive effect was noted.SF-6D index scores generally reflected 
the patterns of influence of DM and chronic medical conditions on SF-36 
scores.This study concluded that DM and chronic medical conditions generally 
reduced HRQoL in this multiethnic general population in an additive,rather than 
synergistic or subtractive fashion.In this study, the SF-6D was a reasonably good 
summary measure for the SF-36. 
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9. Hollman.G,Gullberg.M.,et.al.,(2002), reported a descriptive cross-sectional 
study,to quality of life in patients with familial hypercholestrolemia.In this 
study,result is patients with FH were significantly more satistfied with overall 
quality of life 21.8+_ 0-3 (SEM) vs controls 21.1+_ 0.1 and this was also the case in 
three of four subscales, all differences P<0.05.Anxiety about getting CHD was 
expressed amongest 86% of the patients with FH.This study concludedthat quality of 
life amongst patients FH was at least a good as in controls but they were worried 
about getting CHD. 
10.Laura Hyttinen,Paivi kekalainen,et.al.,(2001)  was conducted a Health-related 
quality of life in elderly patients with familial Hypercholestrolemia.In this study 
concluded that lifelong hypercholesterolemia was not associated with poorer HRQL 
in elderly survivors of FH.These elderly FH individuals are characterized by their 
healthy lifestyle and long-term statin treatment. 
11.Lyne Lalonde,Ann E.Clarke et.al.,(2001),reported a study based on Health-
Related Quality of life with coronary heart disease prevension and treatment.This 
study estimating the net benefits of dyslipidemia treatment is limited by the lack of 
comprehensive and standardized information on the preference for dyslipidemia and 
coronary heart disease.This is a hospital-based study,in this study they measured the 
health-related quality of life (HRQoL) of healthy participants without dyslipidemia 
(n= 251) and patients with coronary heart disease (n= 320).compare to the healthy 
participants without dyslipidemia,those with dyslipidemia reported lower adjusted 
mean scores on the Rating scale (-2.8 points,p= 0.02) and the SF-36 General Health 
Scale (-3.3 points,p=0.02).In summary,this study suggests that in primary 
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prevension, the diagnosis and treatment of duslipidemia may be associated with a 
small but real reduction in HRQoL.      
12.Abdul Rahman Al-Nuaim et.al.,(1996),was conducted a population-based 
cross-sectional study of  population-based epidemiological study on characteristics 
of risk factors of hypercholerolemia in Saudi Arabia.The result of the study is the 
risk of developing HC increased with age by 2% and 1 for each year increase in age 
for borderline high HC and high HC.The risk of developing HC was significantly 
higher among female subjects.There was no significant regional variation for risk of 
borderline high HC,however,there was a significant increase in the risk of  
developing high HC among residents of central and Eastern regions,compared with 
other regions.The conclusion of this characteristics of risk factors for HC among the 
Saudi population differ in many respects from other populations.Overweight and 
obesity are not significant risk factors for HC. Rural communities are more at risk of 
HC than urban communities.The population of the eastern and central regions were 
at significantly higher risk of developing HC.The relatively recent urbanization may 
account for the low prevalence of HC . 
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AIM AND OBJECTIVE 
Aim :   
This study aimed to determine the HQRoL study in patients with 
hypercholestrolemia. 
Objective: 
1. To assess the health related quality of life in patients with 
Hypercholesterolemia. 
2. To determine the socio-demographic and clinical factors that affects the 
quality of life of these patients. 
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PLAN OF THE WORK 
¾ Preparation of Questionnaire: 
 Based on the topic literature review were collected. From the literature review 
prepare the Performa and SF-36 questionnaire form with the help of standard 
references. Preparation questionnaire was interviewed by guide and co-guide. 
¾ Selection of population: 
  Sample size calculation was done to determine the population required for the 
study.To reached the required sample size,200 respondents were selected. From  
the 200 ,150 patients interviewed. Out of 200, filled questionnaire 150 
completely filled questionnaire were selected for the data collection of our study. 
¾ Data Analysis 
 Collected data will be entered in Microsoft excel for analyzing the data. Data 
processing, tabulation of descriptive statistics, calculation of inferential statistics and 
graphical representations will be performed primarily using statistical software 
SPSS for Windows.   
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METHODOLOGY 
 This chapter comprised of study site,study period,study population,study 
design,data collection and data analysis.      
1.Study Site 
       This study conducted in in-patients and out-patients department in Muthoot 
Medical Centre.It is a teritary care hospital in Pathanamthitta,Kerala,with 750  
bedded multispeciality hospitals having Clinical Department such as 
Medicine,Surgery,Endocrinology,Dermatology,ENT,Urology,Paediatrics,Psychiatry
,Orthopaedic and Gynacology. 
2.Study Period 
  Present cross-sectional study was carried out for a period of 10 months from 
June 2011 to March 2012 
3.Study Population 
 Study carries out for a period of 10 months from June 2011-2012. 
4.Study Design                                                                                 
A cross-sectional study design was conducted to describe the HRQoL in 
hypercholestrolemia and the scale of SF-36 used to determine the HRQoL of the 
subjects. 
Inclusion Critria 
¾ Familial Hypercholesterolemia 
¾ Age limit above 30 
¾ Hypertension with Hypercholesterolemia 
¾ Hypercholesterolemia with diabetes 
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¾ Over weight and obese 
¾ Cigertte Smoking 
¾ Cardio vascular disease 
¾ Stroke 
Exclusion Criteria 
¾ ICU patients 
¾ Age limit below 30       
5.Data Collection Tool 
The study will be a cross-sectional study of patients with hypercholestrolemia 
attending the Muthoot Medical Hospital,Pathanamthitta Dist,Kerala. 
6. Questionnare Form 
Questionnare is prepared based on the socio-demographic characteristics of 
hypercholestrolemia for data collection.The patients of are requested to answer a 
questionnare.Questionnare includes the demographical data of patients such as 
age,sex,educational level,martial status,Job,Height,Weight,Familial 
hypercholestrolemia,use of hypercholestrolemic agents,cholesterol levels in clinical 
history,other data on laboratory such as blood pressure and fasting sugar levels,life 
style (smoking cigratte,alcohol) Physical activity,habits(vegetarian and non-
vegetarian). 
The second part of the questionnare that is SF-36 V2 (study 36 item short form 
version-2).This SF-36V2 quetionnare form are trademarks of medical outcomes trust 
and are used under licence (licence no:QM010147).The SF-36 V2 is a National 
Health Measuremet study.The SF-36 V2 health survey was developed to be a 
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brief,broad,generic measure of eight domins,or aspects of health status that are 
considered important in describing and monitoring individuals suffering from a 
disease or illness.Although it measures these domins in terms of 
functioning,behaviorally more subjective states and/or personal evaluations. 
The SF-36V2 includes one favorably scored scale measuring each of eight health 
domains.Physical functioning,Role Participation with physical health problems 
(role-physical),bodily pain,general health,vitality,Social functioning,role 
participation with emotional health problems (role-emotional),Mental health. 
The first and second part of the study was a prospective analysis of files to 
document the HRQoL in hypercholestrolemia patients.All of the questionnares in 
the study was those who affected hypercholestrolemia and its risk factors within the 
last 10 months period prior to the interview.In this study we are enrolled 100 
patients according to inclusion criteria.All information was obtained through face-
to-face interview.Questions were repeated and seek the information from the 
patients during the subsequent monts.Time to complete the questionnare was usually 
between 15-20 minutes.The data regarding the study are made into a  report and 
submitted. 
7.Data Processing And Analysis 
Collected data will be entered in Microsoft excel for analyzing the data 
processing,tabulation of descriptive statics,calculation of inferential statistics and 
graphical representaion will be performed primarily using statical software SPSS for 
windows.Statistical testing will be performed at 5% level of significance.Baseline 
characteristics will be described for all patients enrolled in the study.Descriptive 
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statistics will be provided for all demographic and clinical data.Appropriate 
statistical test will be used to find out the statistical sibnificance between variables. 
  7. Ethical Considerations: 
 Written consent had been obtained from patients attending in the hospital. The 
respondent had the right to refuse or decide to stop the interview. Patients singed as 
their agreement to participate in consent form. All of the information will be kept 
confidentially. College ethical committee approved also has taken. 
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RESULTS 
6. General Description 
The present study was carried out in in-patient and out-patient department of 
Muthoot medical centre, Pathanamthitta dist, Kerala. We are enrolled 100 patients 
according to the inclusion criteria. Patients were classified according to socio-
demographic (age, gender and income), life style (alcoholic and smoker, body 
weight, exercise, sleep status) habits (vegetarian and non-vegetarian).All these 
patients were under therapy. The description of the total population is represented in 
below table 1. 
 Socio-Demographic Characteristic Disributation 
    Table 1: Sex Distribution  
Sex Distribution Number of patients 
Male 52(53.1%) 
Female 46(46.9%) 
      
 Age (age greater or less than 40),level of education and the presence of other 
metabolic risk factors including diabetes, hypertension and BMI classification were 
controlled for in all models.Rhonda Belue et.al.,2009). 
               In our study, more number of male patients compare to female. 
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  Figure.1: Sex Distribution in hypercholesterolemia 
Table 2:  Age Distribution 
Age group Number of patients 
30-49 8 
50-59 15 
60-69 36 
70-79 27 
80-89 12 
 
 Healthy lifestyle has been associated with lower risk of incident coronary 
events among middle-aged women13 and lower risk of CHD mortality in a 
population of elderly men and women.14 Little is known about the relation between 
combined healthy lifestyle choices and incident CHD among middle-aged and older 
men, especially those who are reducing their risk by using drugs for hypertension or 
hypercholesterolemia. (Stephanie E. Chiuve.et.al.,2006) 
Chapter 6 Results 
 
Department of Pharmacy Practice J.K.K.M.M.R.F College of Pharmacy 52
 
Figure 2: Age distribution in hypercholesterolemia 
Among our study, age wise distribution categories into 5 groups. In this 
group more number of patients between 60-69 age group. Less number of patients in 
the age group 30-49.In moderate number of patients in 70-79 age group.50-59 
category numbers of patients is 15 and 80-89 category number of patients is 12. 
Table 3: Education 
EDUCATION NUMBER OF PATIENTS 
Primary School 8 
Secondary School 53 
Higher Study 36 
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Figure 3:  Education Status in hypercholesterolemia patients. 
 In socio-demographic data’s, more number of patients are secondary school 
level and less number of patients are in primary school. Moderate level of patients is 
in higher study. 
Table 4: Body Mass Index 
Body Mass Index Number of patients 
Underweight(18-20) 23 
Normal(21-24) 38 
Obesity(25-27) 37 
 
 BMI ≥ 25 kg/m2 and any two of the following three risk 
factors:hypertension,hyperlipidemia and diabetes.patrick W.sullivan et.al.,2007. 
Participants were asked whether a doctor had advised them to eat fewer high fat or 
high cholesterol foods or to exercise more and also whether they engaged in either 
action.( Kurt J. Greenlund, PhD.et.al.,1999). 
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 In our present study, more number of patients are in normal category. Just 
below the normal category number of patients are obese. Body Mass Index in 
between normal and obesity have only a little range variation. Very less number of 
patients are underweight category. 
 
Figure.4: Body mass index in hypercholesterolemia patients 
Table 5: Alcoholic Consumption 
Alcoholic Consumption Number of patients 
Alcoholic 14(14.3%) 
Non-alcoholic 84(85.7%) 
Chapter 6 Results 
 
Department of Pharmacy Practice J.K.K.M.M.R.F College of Pharmacy 55
 
Figure.5: Alcohol Consumption in hypercholestrolemia patient. 
In our study alcohol intake patients are less than non-alcoholic. Alcoholic 
intake patients 14(14.3%) and non-alcoholic patients 84(85.7%).The average daily 
alcohol intake of 5 to 30 g as low risk. This is consistent with guidelines for 
moderate alcohol consumption,26 although higher amounts of alcohol intake are 
associated with lower risk of CHD. (Stephanie E. Chiuve.et.al.,2006) 
Table 6: Smoking 
Smoking Number of patients 
smoker 59(60.2%) 
Non-smoker 39(39.8%) 
 
 In socio-demographic data’s non-smoker patient is more than smoking 
patients. The risk of CHD among former smokers declins after  smoking cessation, 
approximating the risk of those who have never smoked after 10 to 14 years. 
(Stephanie E. Chiuve,et.al.,2006). 
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Figure.6: Smokers and Non-smokers in hypercholestrolemia 
Table 7: Exercise 
Exercise Number of patients 
yes 59(60.2%) 
no 39(39.8%) 
 
 Those who do regular exercise 59(60.2%) and those who do not do exercise 
39(39.8%). More number of patients was do regular exercise compare to other. For 
exercise, at least 30 min/d of moderate-to-vigorous intensity was considered low 
risk, on the basis of current guidelines.25 Optimal body weight was defined as a 
BMI of _25 kg/m2, the standard World Health Organization cutoff for healthy 
weight.( Stephanie E. Chiuve,et.al.,2006) 
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Table 8: Sleep 
Sleep Number of patients 
Normal 79(80.6%) 
Decreased 18(18.4%) 
Missing 1(1.0%) 
 
 Data were not available regarding counseling for smoking cessation. 
HRQOL was measured by questions ascertaining overall health status and the 
number of the preceding 30 days when physical health was not good, mental health 
was not good, and the person could not carry out usual activities because of poor 
physical or mental health. Kurt J. (Greenlund, PhD.,et.al.,2009) 
 
Figure.8; Sleeping Quality in hypercholestrolemia patients 
 
Normal sleeping patients are 78(80.6%) as the same time 18(18.4%) patients 
are decreased sleeping. More patients are normal sleeping.  
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Table 9. Disease Status 
Disease status Number of patients 
Hypertension 46 
Diabetes Mellitus 32 
Cardiovascular Disease 20 
 
Hypertension
Diabetes Mellitus
Cardiovascular Disease
46
32
20
Number of patients
Number of patients
 
Figure,9: Disease status in Hypercholesterolemia patients 
 According to our study,maximum number of disease status patients are 
having hypertension. Then disease status in Diabetes mellitus. Compare to both 
disease status such as Hypertension,Diabetes Mellitus,Coronary heart disease is less. 
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Table: 10 Differentiation of Body Mass Index 
Characteristics of 
the patients 
Number of 
patients 
BODY MASS INDEX 
18-20 21-24 27-27 
Hypertension with 
Hypercholesterolemia 36 12 11 7 
Diabetes Mellitus 
with 
Hypercholesterolemia
32 8 17 8 
Cardiovascular 
Diseases 14 3 8 3 
Hypercholesterolemia 16 6 8 2 
 
 In this study,characteristics of patients are categorized into 4 groups.Out of 
98 patients, 36 patients who are suffering from hypertension with 
hypercholesterolemia and 32 patients are affected diabetes mellitus with 
hypertension.From patients out of 14 patients having Cardiovascular disease with 
hypercholesterolemia. Hypercholestrolemia is a asymptomatic factor in this 
study.from this study,only 16 patients are affecting hypercholesterolemia. Persons 
with a body mass index _30.0 kg/m2 on the basis of reported height and weight were 
considered obese. (Kurt J. Greenlund, PhD.et.al.,2011) 
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Figure.10: Differentation characteristics in Body Mass Index 
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Table 11:Differentation of Characteristics of social habits 
Characteristics of 
the patients 
Number 
of 
patients 
Smoking Alcohol 
YES NO YES NO 
Hypertension with 
Hypercholesterolemia 36 11 18 8 26 
Diabetes mellitus 
with 
Hypercholesterolemia 
32 6 17 3 27 
Cardiovascular 
Disease with 
Hypercholesterolemia 
14 3 26 2 20 
Hypercholesterolemia 16 2 15 1 16 
 
YES NO YES NO
Number of 
patients
SMOKING ALCOHOL
36
11
18
8
26
32
6
17
4
22
14
3
26
2
20
16
2
15
1
16
Hypertension with Hypercholesterolemia Diabetes Mellitus with Hypercholesterolemia
Cardiovascular Diseases Hypercholesterolemia
                    Figure.11:Differentiation characteristics of social habits 
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Patients those who are more affecting hypercholesterolemia with 
hypertension, the BMI ranges between underweight 16-20.In underweight 
category,12 patients are included. Hypertension with hypercholesterolemia is more 
than compare to the other underweight category. Very less patients are included in 
cardiovascular disease with hypercholesterolemia. 
Next category in between 20-24, more number of patients who are affected 
diabetes mellitus and hypercholesterolemia, just below diabetes mellitus with 
hypercholesterolemia more number in hypertension with hypercholesterolemia BMI 
range between 20-24 hypercholesterolemia with cardiovascular disease is very less. 
Table.12:Laboratory Data Determinations 
Lab Datas 
Normal 
values 
(mg/dl) 
Hyperchole
strolemia 
(no.of 
patients) 
Hypertension 
with 
Hypercholest
rolemia(No 
of patients) 
Diabetes 
mellitus 
with 
Hyperchole
strolemia 
(No of ptnt) 
Cardiovascu
lar disease 
with 
Hypercholes
trolemia (No 
of patients) 
Total 
cholesterol 
<150 6 13 12 8 
>200 10 23 20 6 
TG 60 - 170 4 15 17 4 170- 250 12 21 15 12 
HDL >30 5 16 15 6 <30 11 20 17 8 
LDL <100 7 15 9 2 >100 9 21 23 12 
FBS <125 14 28 7 5 >125 2 8 25 9 
Elevated total serum cholesterol is one of the modifiable risk factors of 
cardiovascular disease , Chih-Hsueh Lin,et.,al.1999. 
 
 
Chapter 6 Results 
 
Department of Pharmacy Practice J.K.K.M.M.R.F College of Pharmacy 63
6  13  12 
8 
10  23  20 
6 
N
o 
of
 p
at
ie
nt
s 
Total cholesterol 
Total cholesterol 
<150 >150
 
Figure 12(a): Clinical laboratory value of Total cholestrol 
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Figure 12(b):Clinical laboratory value of Triglycerides 
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         Figure 12.(c): Clinical laboratory value of HDL 
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Figure 13.(d):Clinical laboratory value of LDL 
The disorder is caused by mutations in the gene that encodes the low density 
lipoprotein cholesterol (LDL-C) levels. The best predictor of LDL-C goal attainment 
was the use of combined therapy with statin and ezetimibe.(Nelva Mata.et.al.,2011) 
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Figure.12(e): cClinical laboratory value of FBS 
 The distinction between co-morbidities and complications of diabetes was 
based on medical records of the patient. Diabetic patients living in the Gaza strip 
camps have a poor HRQOL compared to non-diabetic controls living under the same 
conditions and diabetic patients surveyed in other studies. (Ashraf Eljedi,et.al.,2006) 
Among this study, from clinical profiles, is divided into 5 category. In this 
category total cholesterol is more in hypertension with hypercholesterolemia. Less 
number of total cholesterol in hypercholesterolemia. 
Triglyceride is the second category. From the second category most of the 
patients with normal level of triglyceride level are found in diabetes mellitus with 
hypercholesterolemia patients. From the high triglyceride levels are more in 
hypertension with hypercholesterolemia. 
High density lipoprotein is the next category, from this category most of the 
patients with normal level of HDL level are found in hypercholesterolemia patients. 
Less amount of HDL are found in cardiovascular disease with hypercholesterolemia. 
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In Low density lipoprotein category,most of the patients with normal level 
of LDL are found in hypertension with hypercholestrolemia and more amount of 
LDL level are found in diabetes mellitus with hypercholestrolemia. 
Fasting blood sugar level is the next category,in this category most of the 
patients are normal level of blood sugar in hypertension with 
hypercholestrolemia.More number of pateints are more FBS levels in diabetes 
mellitus with hypercholestrolemia. 
Table 13.Frequency of Reported Health 
Reported Health Number of patients 
+ 13(13.3%) 
++ 1(1.0%) 
_ 38(38.8%) 
__ 7(7.1%) 
0 37(37.8%) 
Missing 2(2.0%) 
13.3 1
38.8
7.1
37.8
2
number of patients
+
++
_
__
0
Missing
 
Figure 13: Frequency of Reported Health 
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In frequency Reported Health 13(13.3%) patients are better health and 
1(1.0%) patients are having better health. 
Out of 98 patients, frequency of reported health 38(38.8%) patients is having 
worse health and 7(7.1%) patients are having worse health condition. In frequency 
of reported health 37(37.8%) patients are having very worse health conditions. In 
frequency of reported health 2(2.0%) patients are missing from this data. 
Table 14.Quality of life Scores 
Scale Item Mean(SD) 
 
 
 
Physical 
Functioning(PF) 
3a.        vigorous activities, such as 
running, lifting   heavy objects, or 
participating in strenuous sports. 
3b .     Moderate activities, such as 
moving table, pushing a vaccum 
cleaner,bowling,or playing golf 
3c.      Lifting or carrying groceries 
3d.     Climbing several flights of 
stairs 
3e.     climbing one flight of stairs 
3f.      Bending,Kneeling,or Stooping 
3g.     Walking more than a mile 
3H.     Walking several hundred yards 
3i.       Walking 100 yards 
3j.       Bathing or dressing oneself 
 
 
 
 
 
47.23 
Bodily Pain (BP) 7. Intensity of bodily pain  
8. Extent pain interfered with normal 
work. 
 
 
 
46.02 
 
 
General Health (GH) 
1.isyour health: excellent,   
Very good, good, fair or poor. 
11 a. seem to get sick a little 
easier than other people. 
11 b. as healthy anybody I know. 
11 c. expect my health to get 
worse. 
11 health is excellent 
 
 
 
 
 
44.41 
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Vitality (V) 
9a.feel full of life. 
9e.have a lot of energy 
9g.feel worn out 
9i.feel tired 
 
48.66 
 
 
Socialfunctioning (SF) 
6. extend health problems 
interfered with normal social 
activites. 
10.frequency health problems 
interfered with social activities. 
 
 
44.01 
 
Role-Emotional 
 
 
 
5a.cut down the amount of time 
spent on work or other activites. 
5b.accomplished less than you 
would like. 
5c.did work or other activites less 
carefully than usual. 
 
 
 
 
 
44.30 
 
 
Mental Health 
 
 
9b.be very nervous. 
9c.felt so dull in the dumps that  
nothing could cheer you up. 
 
9d.Felt carm and peaceful. 
9F.Felt down hearted and 
depressed 
.9h.been happy 
 
 
 
 
51.43 
 
 
Physical 
Component 
Summary 
 
 
 
a) Physical Functioning 
b) Role-Physical 
c) Bodily Pain 
d) General Health 
 
 
 
 
 
 
73.38 
Mental Component 
summary 
a) Vitality 
b) Social Functioning 
c) Role Emotional 
d) Mental Health 
 
71.73 
Total quality of life 
score 
79.62 
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From scores, total quality of life score is more. Physical component 
summary, mental component summary are in same category. Moderate quality of 
life score in mental health. Physical Functioning, Social Functioning, Role 
emotional, Bodily pain, Vitality and general health in low quality of life scores. 
 The Short Form-36 (SF-36) Health Survey, version 2.0 [21] was used to 
assess HRQOL. Its validity, reproducibility and responsiveness to change over time 
have been well demonstrated . It has 36 items that measures the health concepts of 
physical functioning, role limitations due to physical health problems, bodily pain, 
general health, vitality, social function, role limitations due to emotional problems, 
and mental health. It also contains a single item that examines change in health over 
time. Summary measures of physical health (Physical Component Summary [PCS]), 
mental health (Mental Component Summary [MCS]) and Total QOL score (T-score) 
were derived from the completed questionnaire. 
Table 15:level of physical component summary 
QoL Score Percentage of patients 
<60 20.4 
60-70 16.3 
70-80 29.6 
>=80 33.7 
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Figure 15. Level of Physical Component Summary 
 
 
From this graph ,the level of physical component quality of life sore in 
<60,percentage of patients were 20.4 and quality of life score  between 60-70,the 
percentage of patients were 16.3.Level of physical component quality of life 
between  age 70-80,the percentage of patients were 29.6 and the quality of life score 
>=80,the percentage of patients 33.7. 
 Table 16:  level of mental component 
 
QoL Score Percentage of patients 
<60 22.4 
60-70 23.5 
70-80 25.5 
>=80 28.6 
  
             
 
Figure 16. Level of Mental Component Summary 
 
 
Chapter 6 Results 
 
Department of Pharmacy Practice J.K.K.M.M.R.F College of Pharmacy 71
22%
23%
26%
29% < 60
60 ‐ 70
70 ‐ 80
>= 80
 
Figure 16. Level of Mental Component Summary 
 
From the level  of mental component ,the quality of life score <60,percentage 
of patients 22.4 and quality of life between 60-70 the percentage of patients 
23.5.From this graph, the age group between 70-80 the percentage of patients 25.5% 
and quality of life >=80,the percentage of patients 28.6. 
Table 17.level of combined QoL 
QoL Score Percentage of patients 
<60 12.2 
60-70 12.2 
70-80 20.4 
>=80 55.1 
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Figure 17.evel of combined QoL Score 
From this graph, the level of combined quality of life score <60,the 
percentage of patients were 12.2 and quality of life between age  group 60-70,the 
percentage of patients 12.2.Quality of life score between70-80,the percentage of 
patients were 20.4 and quality of life score >=80,the percentage of patients were 
55.1 
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Table 18: Between-group differences in the quality of life score (mean+_SD) as 
a function of socio-demographic profiles. 
Table18 (a):  Quality of life score in socio-demographic profile in gender 
Health domains MALE FEMALE 
Physical Health 46.9±19.9 47.6±21.6 
Role Function 48.9±19.1 44.6±19.1 
Bodily Pain 44.8±12.4 47.4±16.3 
General Health 45.1±11.6 43.7±11.6 
Vitality 46.0±11.6 51.6±10.9** 
Social Function 46.2±17.1 41.6±17.5 
Role - Emotional 44.9±18.6 43.7±17.8 
Mental Health 51.3±10.5 51.5±11.6 
Quality of Life 82.5±19.6 76.3±15.8 
Physical 
Component 
Summary 
77.1±18.7 69.2±13.6 
Mental 
Component 
Summary 
73.5±16.4 69.8±15.9 
(**indicates a significant association (p<0.05) 
From this table, gender has a significant association between vitality in 
quality of life score in socio-demographic profile. 
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Table.18 (c) Quality of life score in socio-demographic profile age group 
 
Health domain 30-69 70-89 
Physical Health 44.9 ± 22.3 49.8 ± 18.6 
Role Function 42.8 ± 19.5 51.4 ± 15.6 
Bodily Pain 48.1 ± 14.9 43.8 ± 13.5 
General Health 44.2 ± 10.3 44.6 ± 12.9 
Vitality 49.3 ± 11.6 48.0 ± 11.6 
Social Function 48.0 ± 17.6 39.6 ± 16.1 
Role - Emotional 38.6 ± 18.3 50.5 ± 16.1 
Mental Health 52.0 ± 10.4 50.9 ± 11.7 
Quality of Life 77.7 ± 18.1 81.7 ± 18.0 
Physical 
Component 
Summary 
70.5 ± 17.6 76.4 ± 15.6 
Mental Component 
Summary 71.1 ± 15.6 72.4 ± 17.0 
 
From this table age group has a significant association with Role-physical, 
Social functioning and Role-Emotional scores. 
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Table18 (b) EDUCATION 
Health Domains literate illiterate 
Physical Health 46.4±20.6 55.6±21.9 
Role Function 46.7±17.6 46.1±24.5 
Bodily Pain 46.1±14.5 41.6±9.6 
General Health 44.3±11.4 43.6±14.4 
Vitality 48.5±11.6 47.7±10.0 
Social Function 44.2±17.8 42.2±13.3 
Physical Health 44.6±18.3 40.6±19.1 
Role - Emotional 51.9±11.2 45.6±6.8 
Mental Health 79.9±18.2 76.6±18.7 
Quality of Life 73.3±17.2 74.0±15.3 
Physical 
Component 
Summary 
72.1±16.4 67.3±15.0 
 
From this table, there is no significant difference between literate and 
illiterate quality of life. 
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Table 18(c): INCOME 
Health Domain <10000 10000-20000 >20000 
Physical Health 43.8±17.5 47.2±21.6 47.8±19.2 
Role Function 35.9±24.1 46.5±18.1 49.5±17.5 
Bodily Pain 55.8±16.8 45.4±14.8 46.2±12.9 
General Health 44.3±13.5 44.0±11.3 45.6±12.4 
Vitality 48.4±3.1 49.2±12.2 47.5±11.0 
Social Function 37.5±10.2 45.3±18.9 41.7±13.4 
Role - Emotional 35.4±22.9 44.2±18.6 46.0±16.7 
Mental Health 53.8±8.5 52.0±11.4 49.6±10.6 
Quality of Life 86.0±25.5 80.4±18.5 76.9±16.0 
Physical 
Component 
Summary 
68.3±15.9 74.1±17.7 72.3±15.2 
Mental 
Component 
Summary 
74.3±28.3 73.2±16.4 67.7±13.4 
 
From this table, there is no significant association between income in quality 
of life score. 
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Table 19.Between –group differences in the quality of life score (mean+_SD) as 
a function of clinical profiles. 
Alcoholic 
Table 19 (a): QUALITY OF LIFE SCORES IN ALCOHOLIC 
Health Domain Alcoholic Non-alcoholic 
Physical Health 60.0±14.8* 45.1±20.8* 
Role Function 46.9±17.5 46.9±18.4 
Bodily Pain 41.0±14.3 46.9±14.3 
General Health 48.8±8.3 43.7±11.9 
Vitality 45.5±11.6 49.2±11.6 
Social Function 45.5±21.1 43.8±16.7 
Role - Emotional 44.0±17.4 44.3±18.4 
Mental Health 57.5±9.6* 50.4±11.0* 
Quality of Life 74.2±15.4 80.5±18.4 
Physical Component 
Summary 69.3±15.0 74.1±17.1 
Mental Component 
Summary 66.2±12.7 72.7±16.6 
 
This group differences in the quality of life score in alcohol as a function of 
clinical profiles, mainly explained about 11 scores.  Alcohol habit has a significant 
association with mental health and physical functioning scores. 
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Excercise  
Table:19(b):Quality of life score in Exercise 
Health Domain Regular exercise Irregular exercise 
Physical Functioning 46.6±21.6 48.2±19.3 
Role-physical 46.2±18.9 47.9±17.3 
Bodily Pain 45.1±15.3 47.4±12.9 
General Health 43.7±12.8 45.5±9.6 
Vitality 49.4±11.5 47.6±11.8 
Social-Functioning 45.8 ±18.4 41.3±15.5 
Role-Emotional           44.2±19.1       44.4±16.9 
Mental Health            50.4±9.9        52.9±12.5 
Quality of life           78.1±18.3        81.9±17.6 
Physical component 
summary 
         71.4±17.0        76.4±16.5 
Mental Component 
summary 
         71.3±16.5        72.3±15.9 
 
 
 The quality of life score, there is no significant association between the quality 
of life score in exercise. 
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Food habits  
Table 19©  :Quality of life style in Food habits 
 
Health 
Domain 
Veg Non-veg Both 
Physical 
Health 
47.1±15.7 45.7±21.6 50.3±20.8 
Role Function 
43.8±9.2 45.9±20.7 50.2±15.4 
Bodily Pain 
48.3±13.6 46.1±14.2 44.9±15.3 
General Health 
46.3 ± 9.5 44.9 ± 11.9 42.7 ± 12.0 
Vitality 
53.1 ± 10.5 47.8 ± 11.8 48.5 ± 11.5 
Social 
Function 
42.7 ± 13.5 43.9 ± 17.7 44.8 ± 18.5 
Role - 
Emotional 
46.5 ± 11.5 42.8 ± 20.7 46.3 ± 15.0 
Mental Health 
46.7 ± 12.7 52.0 ± 11.1 52.2 ± 10.0 
Quality of 
Life 
79.3 ± 14.5 81.1 ± 20.6 76.9 ± 13.6 
Physical 
Component 
Summary 
72.3 ± 11.6 73.9 ± 19.2 72.9 ± 13.8 
Mental 
Component 
Summary 
70.2 ± 16.0 73.8 ± 17.6 68.3 ± 13.0 
From this table there is no significant association between food habits in 
quality of life scores. 
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Sleep status  
Table 19(d):  Quality of life scores in sleep status. 
Health Domain      Normal      Decreased 
Physical Health 
     46.5 ± 21.1       48.8 ± 17.8 
Role Function 
     47.1 ± 18.1        47.6 ± 18.1 
Bodily Pain 
     45.3 ± 13.6       50.1 ± 17.3 
General Health 
     44.0 ± 12.1       46.3 ± 9.6 
Vitality 
     48.3 ± 12.0       50.0 ± 9.6 
Social Function 
      43.4 ± 16.6       47.9 ± 20.2 
Role - Emotional 
43.6 ± 18.6      47.2 ± 16.9 
Mental Health 
      50.9 ± 11.2       53.3 ± 10.3 
Quality of Life 
      79.2 ± 19.4      82.2 ± 11.0 
Physical 
Component 
Summary 
     72.7 ± 17.9      77.3 ± 10.6 
Mental Component 
Summary 
     72.2 ± 17.3      69.5 ± 10.8 
 
From this table, there is no significant association between sleep status in 
quality of life scores. 
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SMOKING 
Among the variables analyzed, smoking has a significant association with 
mental health score in quality of life score. 
Table 19(f):  Quality of life scores in socio-demographic data in smoking 
Health Domain      Smoker    Non-smoker 
Physical Health 
    44.1 ± 20.6     48.1 ± 20.7 
Role Function 
    42.6 ± 16.7     48.1 ± 18.5 
Bodily Pain 
     49.5 ± 14.0      45.0 ± 14.4 
General Health 
     42.6 ± 10.0      44.9 ± 12.0 
Vitality 
     46.3 ± 12.6      49.3 ± 11.3 
Social Function 
     38.1 ± 15.2       45.7 ± 17.6 
Role - Emotional 
     42.0 ± 14.0       45.0 ± 19.2 
Mental Health 
   56.6 ± 9.4*     49.9 ± 11.0* 
Quality of Life 
   83.1 ± 18.1      78.6 ± 18.0 
Physical Component 
Summary 
     75.5 ± 18.6        72.8 ± 16.4 
Mental Component 
Summary 
   74.6 ± 16.7      70.9 ± 16.1 
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DISCUSSION 
6.1 General Observation 
Hypercholesterolemia and its risk factors has become an major cause of 
illness and disability across the world. The number of people with 
hypercholesterolemia is increasing due to population growth, aging, urbanization 
and increasing prevalence of obesity and physical activity. In our present study 100 
hypercholesterolemia patients were enrolled according to our own inclusion criteria. 
They were categorized according to sociodemographic, lifestyle and food habits. 
Gender 
In our study, more number of male patients compare to female. 
Age 
Among our study, age wise distribution is categories into five groups. In this 
group more number of patients between age 60-69.less number of patients in the age 
group 30-49.In moderate number of patients in 70-79 age group.50-59 category, 
number of patients is 15 and 80-89 age group number of patients is 12. 
Education 
In socio-demographic data’s, more number of patients are secondary school 
level and less number of patients are in primary school. Moderate level of patients is 
in higher study. 
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Smoking 
In our patients, more number of patients are less using tobacco. Cigarette 
smoking remains a cardiovascular risk factor. Patients who stop smoking can expect 
an increase of up to 30 percent in their HDL levels. 
Alcohol 
Among maximum number of patients are less taking alcohol. 
Exercise 
Among this study, more number of patients those taking regular exercise, 
compare to others. Physical inactivity is an independent risk factor, raising the risk 
of cardiovascular event twofold. Aerobic exercise raises HDL levels and lowers 
triglyceride levels. When it results in weight loss, it contributes to LDL reduction. 
Sleep 
 In our study normal sleeping patients are more than less sleeping patients. 
Avoiding stress is another main risk factor in hypercholesterolemia. 
Disease Status. 
According to our study, maximum number of disease status patients are 
having hypertension. Then disease status in diabetes mellitus. Compare to both 
disease status such as hypertension,diabetes mellitus,cardiovascular disease is less. 
Disease status is the main risk factors. 
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Body mass index 
In our present study,more number of patients is in normal category.Just 
below the normal category number of patients are obese.Body mass index in 
between normal and obesity have alittle range variation.Very less number of patients 
are in underweight category. Obesity is the main risk factor for 
hypercholesterolemia. Weight maintains is an important guideline for obesity. By 
replacing saturated fats is the main factor to cause over weight.  
Differentiation of characteristics of patients. 
In this study, characteristics of patients are categorized into four groups. Out 
of 98 patient.More number of patients who are suffering from hypertension and 
hypercholesterolemia. Then diabetes mellitus and hypercholesterolemia were 
secondly affecting factors. From patients having cardiovascular disease with 
hypercholesterolemia are in moderate factors. Hypercholesterolemia is a 
asymptomatic factor in this study. From this study, only less patients are affecting 
hypercholesterolemia. 
BMI, is the main risk factor of hypercholesterolemia.BMI,≥ 25kg/m2 is 
considered as cardiometabolic risk factor.Base on the aforementioned risk factor 
definitions,individuals are considered to have cardiometabolic risk factor cluster if 
they had BMI ≥ 25kg/m2 and any two of the following risk 
factors:Hypertension,hyperlipidemia and diabetes.These factors was created for 
cardiometabolic risk factors. 
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BMI is categorized into three groups underweight between 18-20 and normal 
in between 20-24 and obesity 25-27.In this study most of the patients are under thr 
normal category, but only a little differences in between the normal group and 
obesity. Just below the normal group obese patients are more. 
Patients those who are affecting hypercholesterolemia and hypertension,the 
BMI ranges between underweight 16-20.In this underweight category,12 patients are 
included.Hypertension with hypercholesterolemia is more than compare to the other 
underweight category.Very less patients are included in cardiovascular disease and 
hypercholesterolemia. 
Next normal category in between 20-24,more number of patients who are 
affected diabetes mellitus and hypercholesterolemia and just below this category 
more number of patients in hypertension with hypercholesterolemia.In BMI range 
between 20-24 hypercholesterolemia and cardiovascular disease is very less in this 
category. 
In BMI range between 25-27,total number of patients are 20.from this 
category,more number of patients are affecting diabetes mellitus and 
hypercholesterolemia.Then hypertension and hypercholesterolemia is the another 
one in this category,cardiovascular disease with hypercholesterolemia is very less 
compare to other. 
Differentiation of characteristics of patients in social habits. 
According to our study total number of patients are 22 and non-smoker are 
76.The patients who are affecting hypertension with hypercholesterolemia are more 
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smokers and diabetes with hypercholesterolemia is in moderate range.Those who are 
having cardiovascular disease with hypercholesterolemia and hypercholesterolemia 
patients are very less smokers compare to others. Non-smokers are more than 
compare to smokers. In non-smoker group more number of non-smokers are in the 
cardiovascular disease with hypercholesterolemia group. Very less non-smoker 
patients in hypercholesterolemia. 
Among our study population total number alcohol intake patients are 14 and 
non-alcoholic are 84.Compare to alcohol intake patients are less than non-alcohol 
group. In this study more number of patients are more number of patients are in 
hypertension with hypercholesterolemia and less number of patients in 
hypercholesterolemia group.In this study non-alcoholic patients are more in 
hypertension with hypercholesterolemia group less in diabetes mellitus with 
hypercholesterolemia. 
Family history 
Among our study population, more number of patients are having family 
history. Hypertension is the,main syndrome which is affecting more patients in 
family history.Diabetes mellitus is the secondly included in the family history,very 
less in cardiovascular disease. 
Laboratory Data Determination 
The distinction between co-morbidities and complications of diabetes was 
based on medical records of the patient. Diabetic patients living in the Gaza strip 
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camps have a poor HRQOL compared to non-diabetic controls living under the same 
conditions and diabetic patients surveyed in other studies.(Ashraf Eljedi,et.al.,2006) 
Among this study, from clinical profiles, is divided into 5 category. In this 
category total cholesterol is more in hypertension with hypercholesterolemia. Less 
number of total cholesterol in hypercholesterolemia. 
Triglyceride is the second category. From the second category most of the 
patients with normal level of triglyceride level are found in diabetes mellitus with 
hypercholesterolemia patients. From the high triglyceride levels are more in 
hypertension with hypercholesterolemia. 
High density lipoprotein is the next category, from this category most of the 
patients with normal level of HDL level are found in hypercholesterolemia patients. 
Less amount of HDL are found in cardiovascular disease with hypercholesterolemia. 
 In Low density lipoprotein category,most of the patients with normal level 
of LDL are found in hypertension with hypercholestrolemia and more amount of 
LDL level are found in diabetes mellitus with hypercholestrolemia. 
Fasting blood sugar level is the next category,in this category most of the 
patients are normal level of blood sugar in hypertension with 
hypercholestrolemia.More number of pateints are more FBS levels in diabetes 
mellitus with hypercholestrolemia. 
Frequency Reported Health 
In our patients, frequency reported health patients were better health and 
1(1.0%) patients were better health. Outof 98 patients, frequency of reported health 
38(38.8%) patients was having worse health and 7(7.1%) patients are having worse 
health condition. In frequency of reported health patients 37(37.8%) were having 
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very worse health conditions. In frequency of reported health 2(2.0%) patients were 
missing from this data. 
Quality of life scores 
  Among our study,Physical functioning 10 items were included in physical 
functioning. 
1) Physical Functioning 
In physical functioning low scores indicate significant limitations in performing 
physical activities while high scores reflect little or no such limitations.According to 
our study,47.23 is the range in physical functioning. It means in physical functioning 
indicate significant limitations in performing physical activities. 
2)Role-Physical 
   The 4-item RP scale covers ,an array of physical health-related role 
limitations.In our study RP,quality of life score is 43.25.It indicates low scores.low 
scores on RP scales reflect problems with work or other activites as a result of 
physical problem. 
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3) General Health 
The general health scale consist of five items, including a rating of 
health(excellent or poor) and four items addressing the respondents view and 
expectations of his or her health. According to our study population, general health 
quality of life score is 44.41.It indicate low scores. In general health low scores 
indicate evaluation of general health as poor and likely to get worse. 
4) Bodily Pain 
The bodily pain scale comprises two items; one pertaining to the intensity of 
bodily pain and one measuring the extent of interference with normal work activites 
due to pain.In our patients, the quality of life score in BP is 46.02.It indicate low 
scores.In BP low scores indicate high levels of pain that impact normal activities. 
5) Vitality 
Vitality is a 4-item measurement (ie,energy level and fatigue) was developed 
to capture differences in subjective well-being.Among our study the quality of life 
score in vitality is 48.66.It indicate feelings of tiredness and being worn out. 
6) Mental Health 
Mental Health contain five main items.It includes one or more items from 
each of four major mental health dimensions.In our study,mental health scoring is 
high.It indicate feelings of peace,happiness and clam all or most of the time.The 
mental health,quality of lif score is 51.43. 
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7) Social functioning 
SF,is a 2 item scale assess health related effects on quality  and quantity of 
social activites.Here in our study,the quality of life score in SF is 44.30.It indicate 
lowest score.The lowest score indicate extreme or frequent interference with normal 
social activites due to physical and emotional problems. 
8) Role- Emotional 
The 3-item RE assess mental health related role limitation.Among our study, 
RE 44.30 is the quality of life score.Low scores on this scales reflect problems with 
work or other activites as a result of emotional problems. 
Physical Component Summary and  Mental component  
  Among to our study,Physical Component Summary the quality of life score 
is 73.38.In PCS measurement high score indicates little or no physical 
limitations,disabilities as decrements in well-being,a high energy level and good 
general health. 
For Mental Component Summary,the quality of life score is 71.73.it means 
the MCS measures indicate high scores.A high score on the MCS measure indicates 
frequent positive effect,little or no psychological distress or limitations in usual 
social /role activites,due to emotional problems and good general health. 
A strength of PCS and MCS measures in their value in distinguishing a 
physical health outcomes from a mental outcomes. 
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Level of physical Component Summary 
In table 3a, level of physical component summary, quality of life of patients 
less than 60. At the same time quality of life of patient score between 60-70 is very 
low and the score between 70-80,the percentage of patients 29.6 %.Quality of life 
score is greater than or equal to 80,the percentage of patients 33.7 %. 
Level of mental component summary 
In the level of mental component summary, the quality of life scoring is less 
than 60,the percentage of patients 22.4%.Quality of life scoring between 60-70,the 
percentage of patients 23.5%.  Quality of life scoring in between 7-80,25.5% of 
patients and quality of life scoring greater than or equal to 80,the percentage of 
patients 28.6%. 
Level of combined QoL scores 
In table 3c, level of combined QoLscore less than6, the percentage of 
patients is 12.2% and QOL scores in between 70-80,the percentage of patients 
20.4%.As the same time ,QoL score greater than or equal to 80,the percentage of 
patients 55.1. 
Between-group differences in the quality of life score (mean+_SD) as a function 
of socio-demographic profiles. 
Gender 
Of the total study population more number of malesare included in the 
quality of life scores. From the males, more number of quality of life score in Role-
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physical, General-health, Social functioning, Role-motional, Total quality of life 
scores, Physical component summary and mental component summary. More 
number of quality of life score indicate that health is poor condition. 
Of the total study population less number of females, more number of quality 
of life score in physical functioning, Bodily pain, Vitality, Mental health indicate the 
quality of life score health condition is poor.Role physical,General health, Social 
functioning,Role-Emotional,Quality of life scorephysical component summary and 
mental component summary are less quality of life score that indicate health is 
better.Gender has a significant association with VT score. 
AGE GROUP: 
Age group has a significant association with Role of Physical, Social 
Functioning and Role -Emotional in quality of life score. 
 EDUCATION 
From education there is no significant association literate and illiterate in 
quality of life.However, physical function, bodily pain, mental health, mental 
component summary are higher in literate as compare to illiterate. 
 INCOME: 
From income there is no significant association difference between income 
quality of life.  
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Between-group differences in quality of life score (mean+_SD) as a function of 
clinical profile. 
Alcohol 
Alcohol habit has a significant association with mental health and physical 
function scores. However physical function, Role-physical, General health, Vitality, 
social functioning, Mental health, are higher in those are not taking alcohol compare 
to alcohol consumption. 
Body weight 
 From the quality of life score there is no significant association difference 
between body weight. 
Execrise 
 From the quality of life score there is no significant association difference 
between exercise. However physical health, Role-physical, Bodily pain, General 
Health, Role-emotional, mental health, total Quality of life score, Physical 
component summary, mental component summary is higher than in non-alcohol 
consumption. 
Food Habits 
 There is no significant association difference between food habits in the 
quality of life score. 
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Sleep status 
 From the quality of life score there is no significant association difference 
between sleep status. 
Smoking 
 Smoking has a significant association with mental health in quality of life 
score. 
 
Predictors of SF-36 component summary scores - Multivariate Regression 
Analyses reporting standardized beta 
 
Multivariate analyses using multiple linear regression (stepwise selection) were 
performed to identify variables linked to QoL levels. The variables used are Age 
group, Gender, Marital Status, Education, Income, Food Habits, Body Weight and 
Sleep Status. Variable with p-value ≤ 0.15 entered in the model during stepwise 
regression. In the SF-36 model, the PCS and MCS scores were considered separate 
dependent variables. 
A) Physical Component & Quality of Life  
 
 Physical component 
summary (pcs) 
                 p-value 
           Age group                 0.0440 
            Gender                  0.0166 
           Sleep status                   0.0957 
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Age group, Gender and Sleep Status are significantly associated with physical 
component scores. 
Codes: 
Age     :  0 -age<67,   1-age>=67 
Gender:  0-male    ,    1-female 
Sleep   :  0-normal,     1-decreased 
 
B) Mental Component & Quality of Life factors 
 
No Qol factors were significantly associated with Mental Components (Age group, 
Gender, Marital Status, Education, Income, Food Habits, Body Weight and Sleep 
Status – using step-wise regression) 
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CONCLUSION 
 
According to our study from socio-demographic data, BMI, age group, 
disease status, family history are the main factors that increasing 
hypercholesterolemia and its risk factors. In quality of life score, our 
present study, reveals that gender, age, social functioning and Role-
emotional has a strong association with mental health and alcohol 
consumption and smoking.Wereas ,no QoL factors were significantly 
associated with mental components (Age, Gender, Education, Income, 
Food Habits, Body weight and Sleep status).Total quality of life score, 
Physical component summary, mental component summary were high 
in quality of life score.  
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FUTURE RECOMMENDATION 
Hypercholesterolemia, was the major contributors to atherosclerosis and 
coronary heart disease in our society.The National Institutes of Health, has created a 
set of guidelines that standardize the clinical assessment and management of 
hypercholesterolemia for practicing physicians , other professionals in the medical 
community.In addition, to modifying current strategies of risk assessment the new 
guidelines and  stress the importance of an aggressive therapeutic approach in the 
management of hypercholesterolemia.The major risk factors, that modify low-
density lipoprotein goals such as age,smoking,status,hypertensionhigh-
densitylipoprotein levels, and high-density lipoprotein levels, and family history.The 
concept of “CHD equivalent”is introduced-conditions requiring the same vigilance 
used in patients with coronary heart disease.Patients with diabetes and those with a 
10-year cardiac event risk of 20 percent or greater are considered CHD equivalents. 
Once LDL cholesterol  was at an accepted level and physicians were  advised to 
address  metabolic syndrome, hypertriglyceima. 
In our study,hypercholesterolemia may be induced due to lifestyle such as 
overweight, smoking and alcohol drinking and irregular exercise, uncontrolled diet 
.These risk factors were the major problems to increasing cholesterol. 
Among this population more number of patients are affected 
hypercholesterolemia and its related related risk factors such as 
diabetes,hypertension,Coronary heart disease.Some patients are diabetes mellitus 
with hypercholesterolemia,diabetes with hypertension,hypercholesterolemia.In this 
case their quality of life style is very poor. 
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In our study quality of life style in health domain scores are higher.This 
means that the quality of life in hypercholesterolemia patient is poor.Physical 
inactivity and independent risk factor, raising the risk cardiovascular event.Aerobic 
exercise raises HDL level and lower triglyceride levels. Cigarette smoking remains a 
cardiovascular risk factor. Patients who stop smoking can expect an increase of upto 
30% in their HDL level. 
For future recommendation, like this study is mainly helpful  to know the 
quality of life in health and help to reduce the poor health related quality of life. 
Health related quality of life study is mainly helpful to more aware about metabolic 
syndrome such as diabetes,hypertension and dyslipidemia.Some patients are not that 
much aware about this syndrome 
In our population more number of peoples are affected the metabolic 
syndrome.The metabolic syndrome is increasing day by day.The health related 
quality of life survey is more helpful to the patients who are affected metabolic 
syndrome and future affecting patients. 
In future,Health related quality of life study is more beneficial to new 
generation population. A wide range of study population needed in future study. 
Study population is more, and then we have to compare the quality of life scores in 
metabolic syndromes and quality of life scores in gender differences. This health 
related quality of life survey is help to improve the reduction of syndrome. 
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PROFORMA 
ASSESMENT OF HEALTH RELATED QUALITY OF LIFE IN     
SUBJECTS WITH HYPERCHOLESTROLEMIA 
PATIENT DEMOGRAPHIC DATA 
 
Patient Name     :                                            Date: 
 IP/OP no     : 
Age      : 
Sex      : 
wt./ ht      : 
BMI      :    
Marital Status     : 
CHIEF COMPLIANT 
Primary Reason for Visit   : 
Duration of Presenting Symptoms  : 
PAST MEDICAL HISTORY 
 
PAST MEDICATION HISTORY 
 
FAMILY HISTORY 
Presence of any disease   : 
Other family member with similar disease :  
Yes    No  
SOCIAL HISTORY 
Level of education    : 
  
 Economic status: 
Diet :    veg            Non veg  
Habits :   alcohol               Tobacco  
 
Quality of sleep    : 
 
Exercise :   Yes          No  
 
DIAGNOSTIC TEST 
Blood Pressure    : 
Lipid profile     :  
Cholesterol 
Triglycerides 
HDL (good cholesterol) 
LDL (bad cholesterol) 
Fasting blood Sugar level   : 
MANAGEMENT 
DRUG NAME DOSE DURATION FOLLOW UP 
        
        
        
        
        
        
        
 
